surveillance of icu - acquired infections national ... · surveillance of icu - acquired infections...
TRANSCRIPT
Surveillance of ICU - Acquired InfectionsNational Feedback ReportRisk Factor IndicatorsYear 2013
Scientific Institute of Public HealthDirection of Public Health and SurveillanceNational Surveillance of Hospital Infections (NSIH program)
14, Juliette Wytsmanstraat1050 Brussels - Belgiumhttp://www.wiv-isp.behttp://www.nsih.be
Het project wordt financieel ondersteund doorKB van 19 juni 2007 betreffende de vaststelling en de vereffening van het budget van financiële middelenvan de ziekenhuizen
Le projet est financièrement soutenu parAR du 19 juin 2007 relatif à la fixation et à la liquidation du budget des moyens financiers des hôpitaux
Further information on this report:Mr. Karl MertensTel +32 2 642 [email protected]
Surveillance of ICU-acquired InfectionsNational Feedback Report Risk Factor Indicators Year 2013
List of Tables
1 Missing Admission variables . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22 Admission Characteristics (a) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33 Admission Characteristics (b) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44 Admission Characteristics (c) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55 Admission Characteristics (d) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66 Daily Invasive Device exposure indicators . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 77 Missing SOFA Scores . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 88 Daily SOFA score indicators . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99 Daily SOFA score indicators . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1010 Antibiotic Use Population (aggregated) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1111 Antibiotic Use Distribution (aggregated) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1212 Antibiotic Use (exhaustive) (a) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1313 Antibiotic Use (exhaustive) (b) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1414 Antibiotic Use (exhaustive) (c) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1415 Pneumonia and Admission Exposure (a) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1516 Pneumonia and Admission Exposure (b) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1617 Pneumonia and Admission Exposure (c) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1718 Pneumonia and Admission Exposure (d) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1819 Bloodstream Infection and Admission Exposure (a) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1920 Bloodstream Infection and Admission Exposure (b) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2021 Bloodstream Infection and Admission Exposure (c) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2122 Bloodstream Infection and Admission Exposure (d) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2223 Pneumonia and Invasive Device Exposure (a) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2324 Pneumonia and Invasive Device Exposure (b) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2425 Pneumonia and Invasive Device Exposure (c) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2526 Bloodstream Infection and Invasive Device Exposure (a) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2627 Bloodstream Infection and Invasive Device Exposure (b) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2728 Bloodstream Infection and Invasive Device Exposure (c) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2829 Pneumonia and SOFAscore (a) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2930 Pneumonia and SOFAscore (b) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3031 Bloodstream Infections and SOFAscore (a) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3132 Bloodstream Infections and SOFAscore (b) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3233 Pneumonia and Antibiotic Use . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3334 Bloodstream Infection and Antibiotic Use . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3435 Standardized Pneumonia and Bacteremia Rates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3536 Nosocomial Pneumonia and Bacteremia risk score distribution . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
List of Figures
1 Evolution: SAPS II Score Median . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 372 Evolution: Death / DNR (%) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 373 Evolution: Intubation days / 1000 patientdays . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 384 Evolution: CVC days / 1000 patientdays . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 385 Evolution: Any AB utilization days / 1000 patientdays . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 396 Benchhmark: Standardized Pneumonia Ratio . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 397 Benchhmark: Ventilator Associated Pneumonia versus Standardized Pneumonia Ratio . . . . . . . . . . . . . . . 408 Benchhmark: Standardized Bacteremia Ratio . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 419 Benchhmark: Catheter Associated Bacteremia versus Standardized Bacteremia Ratio . . . . . . . . . . . . . . . . 42
Scientific Institute Public Health, Brussels, 12 Nov 2015 12:26:12 1
Surveillance of ICU-acquired InfectionsNational Feedback Report Risk Factor Indicators Year 2013
Tabl
e1:
Mis
sing
Adm
issi
onva
riabl
es
varia
ble
L1a
L2a
Lsa
Req
a#a
%a
p10
p25
p50
p75
p90
disc
harg
eda
tefr
omth
eIC
UV
0M
00.
000.
000.
000.
000.
000.
00di
scha
rge
stat
usV
0R
30.
090.
000.
000.
000.
480.
63di
scha
rge
date
from
the
hosp
ital
V0
O13
23.
970.
000.
000.
000.
957.
32di
scha
rge
stat
usfr
omth
eho
spita
lV
0O
129
3.88
0.00
0.00
0.00
0.95
7.72
SA
PS
IIsc
ore
V0
R26
78.
030.
000.
000.
0043
.36
98.0
4A
PA
CH
EII
scor
eV
0O
267
8.03
0.00
0.00
0.00
43.3
698
.04
PR
ISM
scor
eV
0O
271
8.15
0.00
0.00
0.64
44.2
598
.04
patie
ntor
igin
V0
O3
0.09
0.00
0.00
0.00
0.00
0.48
type
ofad
mis
sion
V0
R6
0.18
0.00
0.00
0.00
0.48
0.82
trau
ma
V0
R15
84.
750.
000.
000.
000.
823.
92im
paire
dim
mun
ityV
0O
155
4.66
0.00
0.00
0.00
0.82
1.96
antim
icro
bial
trea
tmen
tw
ithin
48h
arou
ndad
mis
sion
(<>
48h)
V0
R32
0.96
0.00
0.00
0.00
0.95
1.96
acut
eco
rona
ryca
reV
aR
157
4.72
0.00
0.00
0.00
0.48
1.22
surg
ery
in30
days
befo
read
mis
sion
Va
R2
0.06
0.00
0.00
0.00
0.00
0.63
surg
ery
in30
days
befo
read
mis
sion
Va
R0
0.00
0.00
0.00
0.00
0.00
0.00
Gla
sgow
com
asc
ore,
estim
ated
Va
O73
522
.09
0.00
0.00
0.00
100.
0010
0.00
Gla
sgow
com
asc
ore,
mea
sure
dV
aO
743
22.3
30.
000.
003.
8110
0.00
100.
00to
talp
atie
ntva
riabl
esV
aO
3060
17.0
10.
707.
7022
.61
29.5
329
.90
al1
=le
vel1
varia
ble
(den
omin
ator
-bas
edsu
rvei
llanc
e);l
2=le
vel2
varia
ble
(pat
ient
-bas
edsu
rvei
llanc
e);L
2s=
leve
l2su
bopt
ion
(0=
basi
cle
vel2
varia
bles
a=ex
tra
patie
ntad
mis
sion
and
day
byda
yva
riabl
es,b
=ce
ntra
lvas
cula
rca
thet
erfo
llow
-up,
c=an
timic
robi
altr
eatm
ent
follo
w-u
p);R
eq:
M=
man
dato
ry,R
=R
equi
red,
O=
Opt
iona
l#=
num
ber
ofm
issi
ngva
riabl
es;%
=#
/100
elig
ible
reco
rds
Scientific Institute Public Health, Brussels, 12 Nov 2015 12:26:12 2
Surveillance of ICU-acquired InfectionsNational Feedback Report Risk Factor Indicators Year 2013
Tabl
e2:
Adm
issi
onC
hara
cter
istic
s(a
)
patie
nts
LOS
p50a
SA
PS
IIp5
0aD
eath
/DN
R%
a
#b%
b
agg
p25
p50
p75
agg
p25
p50
p75
agg
p25
p50
p75
agg
p25
p50
p75
Ag
e≤
4059
63
79
54
59
2719
2529
20
00
40-5
918
017
1516
225
45
626
2428
308
37
960
-69
254
2421
2428
54
56
3329
3334
96
713
70-7
412
612
1011
156
46
736
3241
5411
67
1875
-79
158
1513
1417
65
67
3833
3646
1713
1419
≥80
281
2717
2531
54
66
4334
4646
1510
1422
unkn
own
00
00
0
Gen
der
fem
ale
430
4136
3943
64
56
3331
3341
104
1014
mal
e62
859
5761
645
46
636
2936
4612
612
18un
know
n0
00
00
SA
PS
IIsc
ore
≤10
212
00
34
34
56
67
80
00
010
-19
868
04
146
34
616
1515
162
00
020
-29
192
180
1532
54
45
2524
2525
30
37
30-3
920
019
023
265
55
534
3434
345
24
740
-49
137
130
1117
66
67
4444
4446
1514
1515
50-5
970
70
511
66
67
5554
5557
238
1327
≥60
848
26
159
78
1168
6670
7546
3946
60un
know
n26
825
03
985
55
610
08
8
aLO
S=
med
ian
leng
thof
stay
for
patie
nts
adm
itted
with
inth
isca
tego
ry;S
AP
SII=
med
ian
SA
PS
IIsc
ore
for
patie
nts
adm
itted
with
inth
isca
tego
ryb
#=nu
mbe
rof
adm
issi
ons
with
inca
tego
ry;%
=#/
100
tota
ladm
issi
ons
Scientific Institute Public Health, Brussels, 12 Nov 2015 12:26:12 3
Surveillance of ICU-acquired InfectionsNational Feedback Report Risk Factor Indicators Year 2013
Tabl
e3:
Adm
issi
onC
hara
cter
istic
s(b
)
patie
nts
LOS
p50a
SA
PS
IIp5
0aD
eath
/DN
R%
a
#b%
b
agg
p25
p50
p75
agg
p25
p50
p75
agg
p25
p50
p75
agg
p25
p50
p75
Ap
ach
eS
core
<10
81
00
03
33
322
2222
220
00
010
-19
151
00
04
44
426
2626
260
00
020
-29
20
00
07
77
754
5454
540
00
030
-39
10
00
09
99
968
6868
6810
010
010
010
040
-49
00
00
050
-59
00
00
0≥
600
00
00
unkn
own
1032
9810
010
010
06
46
635
3037
4811
89
17
Pat
ien
tO
rig
inot
her
serv
ice
563
5348
5069
64
66
3329
3242
117
819
othe
rIC
U2
00
00
76
78
5551
5558
00
00
com
mun
ity43
741
3044
486
56
641
3343
4811
516
19nu
rsin
gho
me
535
15
76
46
733
3043
5211
00
18un
know
n3
00
00
66
67
3622
3651
00
00
Typ
eo
fA
dm
issi
on
med
ical
736
7051
6286
65
66
4137
4244
159
1722
sche
dule
dsu
rgic
al21
821
418
365
45
629
2728
301
00
2un
sche
dule
dsu
rgic
al98
97
816
85
810
3631
3339
80
911
unkn
own
61
00
15
35
724
2224
370
00
0
aLO
S=
med
ian
leng
thof
stay
for
patie
nts
adm
itted
with
inth
isca
tego
ry;S
AP
SII=
med
ian
SA
PS
IIsc
ore
for
patie
nts
adm
itted
with
inth
isca
tego
ryb
#=nu
mbe
rof
adm
issi
ons
with
inca
tego
ry;%
=#/
100
tota
ladm
issi
ons
Scientific Institute Public Health, Brussels, 12 Nov 2015 12:26:12 4
Surveillance of ICU-acquired InfectionsNational Feedback Report Risk Factor Indicators Year 2013
Tabl
e4:
Adm
issi
onC
hara
cter
istic
s(c
)
patie
nts
LOS
p50a
SA
PS
IIp5
0aD
eath
/DN
R%
a
#b%
b
agg
p25
p50
p75
agg
p25
p50
p75
agg
p25
p50
p75
agg
p25
p50
p75
Trau
ma
no82
478
7891
946
46
641
3042
4412
811
18ye
s76
73
818
85
913
2928
3738
80
010
unkn
own
158
150
14
66
66
2928
2938
80
07
Imp
aire
dIm
mu
nit
yno
806
7678
8597
54
66
3725
3548
115
1318
yes
969
311
177
67
743
4243
4623
2024
29un
know
n15
615
01
26
56
735
3039
458
00
0
An
tib
ioti
cTr
eatm
ent
no44
142
1043
625
45
640
2941
416
04
9ye
s57
054
2856
826
66
737
3141
4815
1220
22un
know
n47
40
19
54
57
3924
4245
150
022
aLO
S=
med
ian
leng
thof
stay
for
patie
nts
adm
itted
with
inth
isca
tego
ry;S
AP
SII=
med
ian
SA
PS
IIsc
ore
for
patie
nts
adm
itted
with
inth
isca
tego
ryb
#=nu
mbe
rof
adm
issi
ons
with
inca
tego
ry;%
=#/
100
tota
ladm
issi
ons
Scientific Institute Public Health, Brussels, 12 Nov 2015 12:26:12 5
Surveillance of ICU-acquired InfectionsNational Feedback Report Risk Factor Indicators Year 2013
Tabl
e5:
Adm
issi
onC
hara
cter
istic
s(d
)
patie
nts
LOS
p50a
SA
PS
IIp5
0aD
eath
/DN
R%
a
#b%
b
agg
p25
p50
p75
agg
p25
p50
p75
agg
p25
p50
p75
agg
p25
p50
p75
Acu
teC
oro
nar
yC
are
no80
576
8086
936
46
638
3036
4211
88
14ye
s95
93
914
65
57
3938
5768
190
1050
unkn
own
158
150
01
44
46
3822
3064
80
04
Pri
or
Su
rger
ysi
teno
690
6549
5377
65
66
4137
4244
159
2023
coro
nary
585
00
184
34
428
2627
402
00
3ot
her
card
iac
636
01
114
44
530
2637
473
00
2ot
her
thor
acic
293
13
65
45
629
2026
350
00
0ot
her
vasc
ular
293
23
45
45
633
2929
337
00
0ab
dom
inal
283
02
514
613
1732
2735
467
00
8ne
uros
urge
ry51
53
48
65
57
3129
3047
100
717
othe
r11
911
811
186
45
730
2930
374
03
8un
know
n0
00
00
aLO
S=
med
ian
leng
thof
stay
for
patie
nts
adm
itted
with
inth
isca
tego
ry;S
AP
SII=
med
ian
SA
PS
IIsc
ore
for
patie
nts
adm
itted
with
inth
isca
tego
ryb
#=nu
mbe
rof
adm
issi
ons
with
inca
tego
ry;%
=#/
100
tota
ladm
issi
ons
Scientific Institute Public Health, Brussels, 12 Nov 2015 12:26:12 6
Surveillance of ICU-acquired InfectionsNational Feedback Report Risk Factor Indicators Year 2013
Table 6: Daily Invasive Device exposure indicators
invasive device #a ratea
agga p10 p25 p50 p75 p90
Intubation days 7830 437.7 161.4 306.0 442.9 473.2 797.7patients with Intubation days 1218 48.3 14.5 42.5 45.1 66.9 84.3
central vascular catheter days 18321 783.9 466.3 709.2 791.4 844.5 949.8patients with central vascular catheter days 2533 77.3 38.3 69.1 77.7 82.8 94.6
urinary catheter days 5702 662.3 0.0 632.9 764.4 873.8 915.7patients with urinary catheter days 703 66.4 0.0 57.2 78.9 90.2 90.3
naso-oro intestinal tube days 2321 269.6 142.6 180.4 230.2 384.1 548.7patients with naso-oro intestinal tube days 446 42.2 14.5 31.7 37.3 55.8 74.5
naso-oro intestinal tube feeding days 2382 276.7 89.8 101.3 269.0 334.3 489.9patients with naso-oro intestinal tube feeding days 250 23.6 5.7 11.9 19.7 25.5 50.4
parenteral feeding days 1211 140.7 60.7 113.6 143.6 196.1 269.0patients with parenteral feeding days 139 13.1 7.1 10.1 13.8 16.4 23.5
invasive mechanical ventilation days 2396 278.3 0.0 155.1 299.2 371.3 508.3patients with invasive mechanical ventilation days 405 38.3 0.0 14.5 42.5 65.6 84.3
non-invasive mechanical ventilation days 403 46.8 0.0 4.9 40.0 65.4 103.3patients with non-invasive mechanical ventilationdays
115 10.9 0.0 1.4 11.3 11.8 24.4
tracheotomy intubation days 426 49.5 0.0 0.0 41.7 70.1 207.9patients with tracheotomy intubation days 31 2.9 0.0 0.0 1.8 5.2 17.6
re-intubation days 25 2.9 0.0 0.0 3.2 3.7 5.4patients with re-intubation days 23 2.2 0.0 0.0 2.0 2.7 4.8
a #=number of days or patients with device exposure; rate=#/1000 patientdays (days); rate=#/100admissions (patients)
Scientific Institute Public Health, Brussels, 12 Nov 2015 12:26:12 7
Surveillance of ICU-acquired InfectionsNational Feedback Report Risk Factor Indicators Year 2013
Tabl
e7:
Mis
sing
SO
FAS
core
s
varia
ble
L1a
L2a
Lsa
Req
a#a
%a
p10
p25
p50
p75
p90
sofa
scor
e,cn
sV
aR
7081
0.00
0.00
0.00
0.00
100.
0010
0.00
sofa
scor
e,re
spira
tion
Va
R73
690.
000.
000.
0065
.00
100.
0010
0.00
sofa
scor
e,co
agul
atio
nV
aR
7096
0.00
0.00
0.00
0.00
100.
0010
0.00
sofa
scor
e,ca
rdio
Va
R70
800.
000.
000.
000.
0010
0.00
100.
00so
fasc
ore,
kidn
eyV
aR
7096
0.00
0.00
0.00
0.00
100.
0010
0.00
sofa
scor
e,liv
erV
aR
7387
0.00
0.00
0.00
69.2
910
0.00
100.
00to
tals
ofa
varia
bles
Va
O43
109
66.9
10.
0021
.07
100.
0010
0.00
100.
00
al1
=le
vel1
varia
ble
(den
omin
ator
-bas
edsu
rvei
llanc
e);l
2=le
vel2
varia
ble
(pat
ient
-bas
edsu
rvei
llanc
e);L
2s=
leve
l2su
bopt
ion
(0=
basi
cle
vel2
varia
bles
a=ex
tra
patie
ntad
mis
sion
and
day
byda
yva
riabl
es,b
=ce
ntra
lvas
cula
rca
thet
erfo
llow
-up,
c=an
timic
robi
altr
eatm
ent
follo
w-u
p);R
eq:
M=
man
dato
ry,R
=R
equi
red,
O=
Opt
iona
l#=
num
ber
ofm
issi
ngva
riabl
es;%
=#
/100
elig
ible
reco
rds
Scientific Institute Public Health, Brussels, 12 Nov 2015 12:26:12 8
Surveillance of ICU-acquired InfectionsNational Feedback Report Risk Factor Indicators Year 2013
Table 8: Daily SOFA score indicators
#a aggb p10b p25b p50b p75b p90b
CNS score0 980 64.1 40.0 40.0 56.9 73.7 73.71 237 15.5 14.5 14.5 16.3 18.2 18.22 105 6.9 4.5 4.5 8.7 12.9 12.93 89 5.8 5.4 5.4 6.1 6.9 6.94 117 7.7 1.9 1.9 12.0 22.1 22.1any 1528 17.7 51.1 51.1 51.4 51.8 51.8scores 0.7 0.5 0.5 0.9 1.4 1.4
Respiratory score0 74 6.0 2.7 2.7 4.6 6.4 6.41 278 22.4 6.1 6.1 15.4 24.6 24.62 448 36.1 28.6 28.6 32.9 37.1 37.13 385 31.0 29.7 29.7 35.3 40.8 40.84 55 4.4 2.1 2.1 11.9 21.8 21.8any 1240 14.4 17.5 17.5 34.3 51.1 51.1scores 2.0 1.8 1.8 2.3 2.7 2.7
Coagulation score0 1125 74.4 69.3 69.3 72.8 76.3 76.31 185 12.2 10.2 10.2 13.8 17.4 17.42 140 9.3 9.0 9.0 9.5 10.0 10.03 54 3.6 3.1 3.1 3.4 3.8 3.84 9 0.6 0.2 0.2 0.5 0.7 0.7any 1513 17.6 50.0 50.0 50.5 51.1 51.1scores 0.5 0.4 0.4 0.5 0.5 0.5
Cardiovacular score0 995 65.1 37.6 37.6 56.8 76.0 76.01 244 16.0 4.8 4.8 24.3 43.8 43.82 13 0.9 0.5 0.5 1.1 1.8 1.83 195 12.8 6.0 6.0 10.7 15.5 15.54 82 5.4 3.2 3.2 7.0 10.8 10.8any 1529 17.8 51.1 51.1 51.5 51.9 51.9scores 0.7 0.7 0.7 0.8 1.0 1.0
a #=number of patientdays; 0/4/any=# of days with SOFAscore=0/4/any
b 0/4=% of days with SOFA score=0/4 among days with anySOFA score; any=% of days with any SOFA score amongtotal patientdays; scores=median score for SOFAcomponent; agg= value obtained when pooling allparticipating units; p=percentiles for the distribution ofparticipating units;
Scientific Institute Public Health, Brussels, 12 Nov 2015 12:26:12 9
Surveillance of ICU-acquired InfectionsNational Feedback Report Risk Factor Indicators Year 2013
Table 9: Daily SOFA score indicators
#a aggb p10b p25b p50b p75b p90b
Renal score0 864 57.1 56.3 56.3 57.8 59.2 59.21 261 17.3 17.0 17.0 17.4 17.8 17.82 168 11.1 9.8 9.8 12.1 14.5 14.53 83 5.5 5.3 5.3 5.6 5.9 5.94 137 9.1 2.6 2.6 7.1 11.5 11.5any 1513 17.6 50.2 50.2 50.6 51.0 51.0scores 1.0 0.7 0.7 0.9 1.0 1.0
Liver score0 987 80.8 76.7 76.7 79.0 81.2 81.21 133 10.9 10.7 10.7 11.6 12.4 12.42 62 5.1 4.7 4.7 6.6 8.5 8.53 22 1.8 1.7 1.7 2.0 2.3 2.34 18 1.5 0.0 0.0 0.8 1.6 1.6any 1222 14.2 15.4 15.4 33.2 51.1 51.1scores 0.4 0.3 0.3 0.3 0.4 0.4
Total score0/1 94 8.2 0.0 0.0 4.3 8.6 8.62 228 20.0 0.0 0.0 10.5 20.9 20.93/4 301 26.4 3.8 3.8 15.6 27.4 27.45/6 187 16.4 7.7 7.7 12.2 16.8 16.87/max 332 29.1 26.2 26.2 57.4 88.5 88.5any 1142 13.3 6.2 6.2 28.6 51.0 51.0scores 6.1 4.9 4.9 7.8 10.7 10.7
a #=number of patientdays; 0/4/any=# of days with SOFAscore=0/4/any
b 0/4=% of days with SOFA score=0/4 among days with anySOFA score; any=% of days with any SOFA score amongtotal patientdays; scores=median score for SOFAcomponent; agg= value obtained when pooling allparticipating units; p=percentiles for the distribution ofparticipating units;
Scientific Institute Public Health, Brussels, 12 Nov 2015 12:26:12 10
Surveillance of ICU-acquired InfectionsNational Feedback Report Risk Factor Indicators Year 2013
Tabl
e10
:A
ntib
iotic
Use
Pop
ulat
ion
(agg
rega
ted)
Pat
ient
s,#a
Pat
ient
days
,#a
agg
p10
p25
p50
p75
p90
agg
p10
p25
p50
p75
p90
patie
nts
with
AB
use
511
141
141
163
207
207
4801
1268
1268
1587
1946
1946
units
with
AB
use
613
157
157
210
246
246
5302
1325
1325
1838
2139
2139
aP
atie
nts,
#=nu
mbe
rof
patie
nts;
Pat
ient
days
,#=
num
ber
ofpa
tient
days
;agg
=ag
greg
ated
over
allp
artic
ipat
ing
units
;p1
0-p9
0=pe
rcen
tile
ofdi
strib
utio
nof
part
icip
atin
gun
its
Scientific Institute Public Health, Brussels, 12 Nov 2015 12:26:12 11
Surveillance of ICU-acquired InfectionsNational Feedback Report Risk Factor Indicators Year 2013
Tabl
e11
:A
ntib
iotic
Use
Dis
trib
utio
n(a
ggre
gate
d)
#a%
ain
cda
agg
agg
p10
p25
p50
p75
p90
agg
p10
p25
p50
p75
p90
Tota
lAB
days
4835
912
880
880
893
948
948
AB
days
with
SD
Dus
e0
00
00
00
00
00
00
AB
days
with
Pro
fyla
ctic
use
330
71
15
1818
6212
1245
159
159
AB
days
with
Em
piric
alus
e26
5855
4343
4872
7250
138
038
045
364
464
4A
Bda
ysw
ithM
icro
orga
nism
know
n86
20
00
44
160
00
4040
AB
days
with
Ant
ibio
gram
know
n17
6136
2727
3943
4333
223
723
734
040
940
9
a#=
num
ber
ofA
ntib
otic
days
with
part
icul
arus
e;%
=#
AB
days
/100
tota
lAB
days
;inc
d=#
AB
days
/100
0pa
tient
days
ofun
itsw
ithA
Bus
e;ag
g=ag
greg
ated
over
allp
artic
ipat
ing
units
;p10
-p90
=pe
rcen
tile
ofdi
strib
utio
nof
part
icip
atin
gun
its
Scientific Institute Public Health, Brussels, 12 Nov 2015 12:26:12 12
Surveillance of ICU-acquired InfectionsNational Feedback Report Risk Factor Indicators Year 2013
Table 12: Antibiotic Use (exhaustive) (a)
Antibiotic pats patdays Antibiotic days, #a
# # T S P E M A
all 4835 0 330 2658 86 1761
J01C PENICILLINS 295 3265 1865 0 44 1166 31 624J01CA Penicillins extended spectrum 28 684 215 0 0 20 3 192J01CA01 Ampicillin 6 171 40 0 0 7 2 31J01CA04 Amoxicillin 3 105 26 0 0 0 0 26J01CA17 Temocillin 23 601 149 0 0 13 1 135J01CE Beta-lactamase sens. penicillins 1 3 3 0 0 0 0 3J01CE08 Benzathine benzylpenicillin 1 3 3 0 0 0 0 3J01CF SS-lactamase resist. penicillins 14 347 116 0 0 1 0 115J01CF02 Cloxacillin 1 18 1 0 0 0 0 1J01CF04 Oxacillin 8 183 48 0 0 0 0 48J01CF05 Flucloxacillin 5 146 67 0 0 1 0 66J01CG SS-lactamase inhibitors 67 785 346 0 0 229 13 104J01CG02 Tazobactam 67 785 346 0 0 229 13 104J01CR SS-lactam + SS-lactamase inhibitor 224 2223 1185 0 44 916 15 210J01CR01 Ampicillin + sulbactam 2 9 9 0 0 9 0 0J01CR02 Amoxicillin + clavulanic acid 188 1702 862 0 39 686 15 122J01CR05 Piperacilline + Tazobactam 50 728 314 0 5 221 0 88
J01D OTH. SS-LACTAM AB,INCL.CEPHALOSP. 294 3230 1585 0 224 778 13 570J01DA Cephalosporins 265 2854 1194 0 224 569 12 389J01DA04 Cefazolin 109 709 206 0 199 7 0 0J01DA06 Cefuroxime 67 680 306 0 25 165 9 107J01DA10 Cefotaxime 7 77 33 0 0 14 1 18J01DA11 Ceftazidime 59 1162 313 0 0 164 2 147J01DA13 Ceftriaxone 50 699 236 0 0 161 0 75J01DA24 Cefepime 13 354 98 0 0 56 0 42J01DA34 Cefacetrile 1 9 2 0 0 2 0 0J01DH Carbapenems 46 1046 391 0 0 209 1 181J01DH02 Meropenem 43 1015 378 0 0 203 1 174J01DH51 Imipenem and enzyme inhibitor 3 31 13 0 0 6 0 7
a T=total use; S=SDD use; P=Profylactic use; E=Empirical use; M=Microorganism known; A=Antibogram known
Scientific Institute Public Health, Brussels, 12 Nov 2015 12:26:12 13
Surveillance of ICU-acquired InfectionsNational Feedback Report Risk Factor Indicators Year 2013
Table 13: Antibiotic Use (exhaustive) (b)
Antibiotic pats patdays Antibiotic days, #a
# # T S P E M A
J01E SULFONAMIDES AND COMBINATIONS 9 178 57 0 10 22 0 25J01EA Trimethoprim 7 160 43 0 10 16 0 17J01EA01 Trimethoprim 7 160 43 0 10 16 0 17J01EE Sulfonamides + trimethoprim + deriv 2 18 14 0 0 6 0 8J01EE02 Sulfadiazine + trimethoprim 2 18 14 0 0 6 0 8
J01F MACROLIDES AND LINCOSAMIDES 49 553 290 0 4 227 10 49J01FA Macrolides + Synergistins 39 448 222 0 0 182 10 30J01FA09 Clarithromycin 39 448 222 0 0 182 10 30J01FF Lincosamides 10 105 68 0 4 45 0 19J01FF01 Clindamycin 10 105 68 0 4 45 0 19
J01G AMINOGLYCOSIDE ANTIBACTERIALS 63 864 194 0 2 99 4 89J01GB Aminoglycosides other than strep 63 864 194 0 2 99 4 89J01GB03 Gentamicin 4 53 22 0 2 0 0 20J01GB06 Amikacin 59 811 172 0 0 99 4 69
J01M QUINOLONE ANTIBACTERIALS 40 592 209 0 14 127 1 67J01MA Fluoroquinolones 40 592 209 0 14 127 1 67J01MA02 Ciprofloxacin 24 343 125 0 3 95 0 27J01MA06 Norfloxacin 1 5 5 0 5 0 0 0J01MA12 Levofloxacin 7 158 41 0 6 3 1 31J01MA14 Moxifloxacin 8 86 38 0 0 29 0 9
J01R COMBINATIONS OF DIFFERENT AB’s 1 8 2 0 0 2 0 0J01RA Combinations of different ab’s 1 8 2 0 0 2 0 0J01RA01 Penicill + other antibacterials 1 8 2 0 0 2 0 0
a T=total use; S=SDD use; P=Profylactic use; E=Empirical use; M=Microorganism known; A=Antibiogramknown
Table 14: Antibiotic Use (exhaustive) (c)
Antibiotic pats patdays Antibiotic days, #a
# # T S P E M A
J01X OTHER ANTIBACTERIALS 49 1062 404 0 3 124 6 271J01XA Glycopeptide antibacterials 42 803 293 0 0 101 5 187J01XA01 Vancomycin 42 803 287 0 0 101 5 181J01XA02 Teicoplanin 1 36 6 0 0 0 0 6J01XB Polymyxins 3 169 50 0 0 4 1 45J01XB01 Colistin 3 169 50 0 0 4 1 45J01XD Imidazole derivatives 6 174 48 0 3 19 0 26J01XD01 Metronidazole 6 174 48 0 3 19 0 26J01XX08 Linezolid 2 52 13 0 0 0 0 13
J02A ANTIMYCOTICS FOR SYSTEMIC USE 20 444 122 0 6 59 10 47J02AA Antifungal antibiotics 2 49 7 0 0 0 0 7J02AB Imidazole antimycotics 3 32 21 0 0 18 0 3J02AC Triazole derivative antimycotics 16 370 88 0 6 35 10 37J02AC01 Fluconazole 16 370 88 0 6 35 10 37J02AX Other systemic antimycotics 2 19 6 0 0 6 0 0J02AX04 Caspofungin 2 19 6 0 0 6 0 0
J04A TREATMENT OF TUBERCULOSIS 1 9 1 0 0 0 0 1J04AB Antimycobacterial antibiotics 1 9 1 0 0 0 0 1J04AB02 Rifampicin 1 9 1 0 0 0 0 1
a T=total use; S=SDD use; P=Profylactic use; E=Empirical use; M=Microorganism known; A=Antibogramknown
Scientific Institute Public Health, Brussels, 12 Nov 2015 12:26:12 14
Surveillance of ICU-acquired InfectionsNational Feedback Report Risk Factor Indicators Year 2013
Tabl
e15
:P
neum
onia
and
Adm
issi
onE
xpos
ure
(a)
pats
apa
tday
saN
Pa
IAP
a
#b%
b#b
%b
#b%
bin
cdb
#bin
cdb
agg
agg
agg
agg
agg
agg
p10
p25
p50
p75
p90
agg
p10
p25
p50
p75
p90
agg
agg
p10
p25
p50
p75
p90
Ag
e≤
4059
5.6
459
5.3
11.
70.
00.
00.
00.
010
.02.
20.
00.
00.
00.
07.
71
6.3
0.0
0.0
0.0
0.0
20.8
40-5
918
017
.015
7218
.38
4.4
0.0
0.0
4.0
7.4
9.1
5.1
0.0
0.0
5.0
7.8
10.1
58.
70.
00.
06.
619
.825
.060
-69
254
24.0
1983
23.0
124.
70.
00.
03.
38.
912
.06.
10.
00.
05.
011
.220
.88
10.8
0.0
0.0
12.2
15.6
26.3
70-7
412
611
.910
2411
.94
3.2
0.0
0.0
0.0
5.9
11.1
3.9
0.0
0.0
0.0
8.2
11.4
24.
90.
00.
00.
00.
014
.775
-79
158
14.9
1382
16.1
127.
60.
00.
06.
714
.321
.18.
70.
00.
07.
515
.522
.28
15.4
0.0
0.0
0.0
26.3
35.3
≥80
281
26.6
2189
25.4
82.
80.
00.
02.
67.
710
.53.
70.
00.
03.
06.
813
.54
6.7
0.0
0.0
4.9
11.4
12.8
unkn
own
00.
00
0.0
00
Gen
der
fem
ale
430
40.6
3259
37.9
133.
00.
00.
03.
17.
08.
34.
00.
00.
04.
29.
19.
57
6.6
0.0
0.0
4.7
14.3
37.0
mal
e62
859
.453
5062
.132
5.1
0.0
1.4
3.3
9.6
12.0
6.0
0.0
2.1
2.8
12.4
13.3
2110
.90.
04.
37.
914
.818
.1un
know
n0
0.0
00.
00
0
SA
PS
IIsc
ore
≤10
212.
010
11.
20
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
00.
00.
00.
00.
00.
00.
010
-19
868.
156
56.
63
3.5
0.0
0.0
0.0
2.3
15.4
5.3
0.0
0.0
0.0
3.0
40.0
110
.20.
00.
00.
08.
917
.920
-29
192
18.1
1420
16.5
84.
20.
01.
82.
65.
47.
45.
60.
02.
05.
36.
510
.36
14.4
0.0
6.1
14.9
19.9
31.3
30-3
920
018
.915
6218
.14
2.0
0.0
0.0
1.7
1.8
4.3
2.6
0.0
0.0
2.0
2.1
6.0
37.
00.
03.
57.
19.
211
.240
-49
137
12.9
1407
16.3
128.
81.
75.
98.
313
.623
.18.
52.
06.
410
.310
.616
.68
13.7
0.0
0.0
7.2
20.5
21.0
50-5
970
6.6
649
7.5
45.
70.
00.
09.
112
.516
.76.
20.
00.
06.
311
.119
.63
10.7
0.0
0.0
12.0
21.3
22.2
≥60
847.
995
511
.110
11.9
0.0
0.0
11.8
20.0
22.2
10.5
0.0
0.0
8.9
12.8
22.3
58.
80.
00.
02.
48.
430
.9un
know
n26
825
.319
5022
.74
1.5
0.0
0.0
2.0
4.0
14.3
2.1
0.0
0.0
1.7
5.8
19.6
23.
20.
00.
01.
46.
49.
9
apa
ts=
patie
nts
patd
ays=
patie
ntda
ysN
P=
Nos
ocom
ialP
neum
onia
;IA
P=
Intu
batio
nA
ssoc
iate
dN
Pb
#=cr
ude
num
ber;
pats
/pat
days
%=
perc
enta
geof
tota
lpat
s/pa
tday
s;N
P%
=#
NP
/100
patie
nts;
NP
incd
=#
NP
/100
0pa
tient
days
;IA
Pin
cd=
#N
P/1
000
intu
batio
nda
ys(b
efor
e1s
tNP
);IU
R=
Intu
batio
nU
tiliz
atio
nR
ate,
intu
batio
nda
ys/1
000
patie
ntda
ys
Scientific Institute Public Health, Brussels, 12 Nov 2015 12:26:12 15
Surveillance of ICU-acquired InfectionsNational Feedback Report Risk Factor Indicators Year 2013
Tabl
e16
:P
neum
onia
and
Adm
issi
onE
xpos
ure
(b)
pats
apa
tday
saN
Pa
IAP
a
#b%
b#b
%b
#b%
bin
cdb
#bin
cdb
agg
agg
agg
agg
agg
agg
p10
p25
p50
p75
p90
agg
p10
p25
p50
p75
p90
agg
agg
p10
p25
p50
p75
p90
AP
AC
HE
sco
re<
108
0.8
250.
30
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
00.
00.
00.
00.
00.
00.
010
-19
151.
416
82.
02
13.3
13.3
13.3
13.3
13.3
13.3
11.9
11.9
11.9
11.9
11.9
11.9
221
.121
.121
.121
.121
.121
.120
-29
20.
213
0.2
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00
0.0
0.0
0.0
0.0
0.0
0.0
30-3
91
0.1
90.
10
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
00.
00.
00.
00.
00.
00.
040
-49
00.
00
0.0
00
50-5
90
0.0
00.
00
0≥
600
0.0
00.
00
0un
know
n10
3297
.583
9497
.543
4.2
0.0
2.0
3.1
8.0
10.2
5.1
0.0
1.7
3.8
10.7
12.1
269.
00.
02.
76.
713
.419
.5
Pat
ien
tO
rig
inot
her
serv
ice
563
53.2
4813
55.9
315.
50.
00.
04.
87.
410
.46.
40.
00.
05.
811
.012
.418
9.9
0.0
0.0
8.0
12.8
14.1
othe
rIC
U2
0.2
140.
20
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
00.
00.
00.
00.
00.
00.
0co
mm
unity
437
41.3
3438
39.9
143.
20.
01.
14.
39.
19.
34.
10.
01.
43.
310
.311
.710
9.0
0.0
4.7
7.9
9.9
24.8
nurs
ing
hom
e53
5.0
326
3.8
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00
0.0
0.0
0.0
0.0
0.0
0.0
unkn
own
30.
318
0.2
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00
0.0
0.0
0.0
0.0
0.0
0.0
Typ
eo
fA
dm
issi
on
med
ical
736
69.6
5859
68.1
243.
30.
00.
02.
47.
113
.74.
10.
00.
02.
99.
511
.317
9.1
0.0
0.0
6.1
14.6
23.8
sche
dule
dsu
rgi-
cal
218
20.6
1475
17.1
136.
00.
00.
04.
58.
09.
18.
80.
00.
07.
112
.215
.06
11.6
0.0
0.0
9.2
15.7
34.5
unsc
hedu
led
surg
ical
989.
312
3314
.37
7.1
0.0
0.0
6.3
14.3
18.2
5.7
0.0
0.0
3.3
10.9
15.3
58.
30.
00.
00.
019
.030
.8
unkn
own
60.
642
0.5
116
.70.
00.
00.
025
.025
.023
.80.
00.
00.
031
.331
.30
0.0
0.0
0.0
0.0
0.0
0.0
apa
ts=
patie
nts
patd
ays=
patie
ntda
ysN
P=
Nos
ocom
ialP
neum
onia
;IA
P=
Intu
batio
nA
ssoc
iate
dN
Pb
#=cr
ude
num
ber;
pats
/pat
days
%=
perc
enta
geof
tota
lpat
s/pa
tday
s;N
P%
=#
NP
/100
patie
nts;
NP
incd
=#
NP
/100
0pa
tient
days
;IA
Pin
cd=
#N
P/1
000
intu
batio
nda
ys(b
efor
e1s
tN
P);
IUR
=In
tuba
tion
Util
izat
ion
Rat
e,in
tuba
tion
days
/100
0pa
tient
days
Scientific Institute Public Health, Brussels, 12 Nov 2015 12:26:12 16
Surveillance of ICU-acquired InfectionsNational Feedback Report Risk Factor Indicators Year 2013
Tabl
e17
:P
neum
onia
and
Adm
issi
onE
xpos
ure
(c)
pats
apa
tday
saN
Pa
IAP
a
#b%
b#b
%b
#b%
bin
cdb
#bin
cdb
agg
agg
agg
agg
agg
agg
p10
p25
p50
p75
p90
agg
p10
p25
p50
p75
p90
agg
agg
p10
p25
p50
p75
p90
Trau
ma
no82
477
.965
3075
.925
3.0
0.0
2.5
3.0
3.6
7.5
3.8
0.0
2.1
3.5
5.2
10.1
167.
80.
03.
86.
211
.716
.7ye
s76
7.2
822
9.5
79.
20.
00.
05.
610
.060
.08.
50.
00.
04.
813
.828
.67
17.5
0.0
0.0
13.0
26.0
44.1
unkn
own
158
14.9
1257
14.6
138.
20.
00.
00.
00.
08.
610
.30.
00.
00.
00.
010
.75
9.3
0.0
0.0
4.7
9.5
9.5
Imp
aire
dIm
mu
nit
yno
806
76.2
6432
74.7
253.
10.
00.
02.
53.
88.
23.
90.
00.
02.
65.
611
.017
8.3
0.0
3.1
8.2
9.3
19.7
yes
969.
184
19.
84
4.2
0.0
0.0
0.0
5.9
8.6
4.8
0.0
0.0
0.0
5.3
9.9
38.
40.
00.
00.
00.
019
.5un
know
n15
614
.713
3615
.516
10.3
0.0
0.0
0.0
0.0
10.6
12.0
0.0
0.0
0.0
0.0
12.3
813
.30.
00.
00.
013
.513
.5
An
tib
ioti
cTr
eatm
ent
no44
141
.731
2536
.316
3.6
0.0
0.0
3.7
13.0
100.
05.
10.
00.
04.
819
.655
.69
9.6
0.0
0.0
6.5
11.6
38.5
yes
570
53.9
5107
59.3
264.
60.
02.
23.
26.
79.
35.
10.
01.
73.
58.
711
.817
9.1
0.0
2.8
8.1
14.9
17.3
unkn
own
474.
437
74.
43
6.4
0.0
0.0
0.0
0.0
11.1
8.0
0.0
0.0
0.0
0.0
10.3
210
.70.
00.
05.
410
.810
.8
apa
ts=
patie
nts
patd
ays=
patie
ntda
ysN
P=
Nos
ocom
ialP
neum
onia
;IA
P=
Intu
batio
nA
ssoc
iate
dN
Pb
#=cr
ude
num
ber;
pats
/pat
days
%=
perc
enta
geof
tota
lpat
s/pa
tday
s;N
P%
=#
NP
/100
patie
nts;
NP
incd
=#
NP
/100
0pa
tient
days
;IA
Pin
cd=
#N
P/1
000
intu
batio
nda
ys(b
efor
e1s
tNP
);IU
R=
Intu
batio
nU
tiliz
atio
nR
ate,
intu
batio
nda
ys/1
000
patie
ntda
ys
Scientific Institute Public Health, Brussels, 12 Nov 2015 12:26:12 17
Surveillance of ICU-acquired InfectionsNational Feedback Report Risk Factor Indicators Year 2013
Tabl
e18
:P
neum
onia
and
Adm
issi
onE
xpos
ure
(d)
pats
apa
tday
saN
Pa
IAP
a
#b%
b#b
%b
#b%
bin
cdb
#bin
cdb
agg
agg
agg
agg
agg
agg
p10
p25
p50
p75
p90
agg
p10
p25
p50
p75
p90
agg
agg
p10
p25
p50
p75
p90
Acu
teC
oro
nar
yC
are
no80
576
.165
7076
.323
2.9
0.0
2.3
2.9
3.9
6.7
3.5
0.0
1.9
3.4
4.8
9.2
177.
90.
03.
26.
411
.816
.1ye
s95
9.0
706
8.2
66.
30.
00.
00.
011
.113
.08.
50.
00.
00.
012
.316
.13
12.3
0.0
0.0
0.0
18.2
28.2
unkn
own
158
14.9
1333
15.5
1610
.10.
00.
00.
05.
210
.512
.00.
00.
00.
06.
112
.38
13.4
0.0
0.0
6.8
13.7
13.7
Pri
or
Su
rger
ysi
teno
690
65.2
5373
62.4
233.
30.
00.
02.
69.
114
.94.
30.
00.
03.
511
.411
.916
9.2
0.0
0.0
7.0
13.2
26.1
coro
nary
585.
534
03.
94
6.9
0.0
0.0
4.5
8.6
8.6
11.8
0.0
0.0
8.7
13.6
13.6
212
.70.
00.
011
.215
.215
.2ot
her
card
iac
636.
040
54.
73
4.8
0.0
0.0
0.0
0.0
6.7
7.4
0.0
0.0
0.0
0.0
9.3
16.
10.
00.
00.
08.
08.
0ot
her
thor
acic
292.
725
93.
04
13.8
0.0
0.0
5.6
16.7
50.0
15.4
0.0
0.0
8.8
21.7
22.2
254
.10.
00.
026
.397
.714
2.9
othe
rva
scul
ar29
2.7
339
3.9
26.
90.
00.
00.
025
.025
.05.
90.
00.
00.
05.
255
.61
7.7
0.0
0.0
0.0
0.0
9.3
abdo
min
al28
2.6
407
4.7
517
.90.
00.
015
.420
.033
.312
.30.
00.
011
.413
.216
.42
7.8
0.0
0.0
7.4
18.2
21.7
neur
osur
gery
514.
852
56.
13
5.9
0.0
0.0
0.0
11.1
33.3
5.7
0.0
0.0
0.0
20.4
23.3
315
.30.
00.
00.
034
.547
.6ot
her
119
11.2
1005
11.7
10.
80.
00.
00.
00.
08.
31.
00.
00.
00.
00.
07.
41
3.1
0.0
0.0
0.0
0.0
19.6
unkn
own
00.
00
0.0
00
apa
ts=
patie
nts
patd
ays=
patie
ntda
ysN
P=
Nos
ocom
ialP
neum
onia
;IA
P=
Intu
batio
nA
ssoc
iate
dN
Pb
#=cr
ude
num
ber;
pats
/pat
days
%=
perc
enta
geof
tota
lpat
s/pa
tday
s;N
P%
=#
NP
/100
patie
nts;
NP
incd
=#
NP
/100
0pa
tient
days
;IA
Pin
cd=
#N
P/1
000
intu
batio
nda
ys(b
efor
e1s
tN
P);
IUR
=In
tuba
tion
Util
izat
ion
Rat
e,in
tuba
tion
days
/100
0pa
tient
days
Scientific Institute Public Health, Brussels, 12 Nov 2015 12:26:12 18
Surveillance of ICU-acquired InfectionsNational Feedback Report Risk Factor Indicators Year 2013
Tabl
e19
:B
lood
stre
amIn
fect
ion
and
Adm
issi
onE
xpos
ure
(a)
pats
apa
tday
saN
Ba
CA
Ba
#b%
b#b
%b
#b%
bin
cdb
#bin
cdb
agg
agg
agg
agg
agg
agg
p10
p25
p50
p75
p90
agg
p10
p25
p50
p75
p90
agg
agg
p10
p25
p50
p75
p90
Ag
e≤
4059
5.6
459
5.3
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00
0.0
0.0
0.0
0.0
0.0
0.0
40-5
918
017
.015
7218
.38
4.4
0.0
0.0
4.0
7.5
11.1
5.1
0.0
0.0
5.0
7.5
11.6
76.
30.
00.
05.
210
.313
.060
-69
254
24.0
1983
23.0
52.
00.
00.
00.
04.
45.
02.
50.
00.
00.
05.
65.
85
3.5
0.0
0.0
0.0
6.1
8.0
70-7
412
611
.910
2411
.93
2.4
0.0
0.0
0.0
5.0
14.3
2.9
0.0
0.0
0.0
5.0
12.3
22.
70.
00.
00.
04.
28.
375
-79
158
14.9
1382
16.1
10.
60.
00.
00.
00.
03.
10.
70.
00.
00.
00.
03.
51
1.1
0.0
0.0
0.0
0.0
5.2
≥80
281
26.6
2189
25.4
31.
10.
00.
00.
02.
64.
81.
40.
00.
00.
03.
45.
13
2.1
0.0
0.0
0.0
3.7
5.9
unkn
own
00.
00
0.0
00
Gen
der
fem
ale
430
40.6
3259
37.9
51.
20.
00.
01.
82.
12.
51.
50.
00.
02.
32.
83.
65
2.2
0.0
0.0
2.5
3.6
4.5
mal
e62
859
.453
5062
.115
2.4
0.0
0.0
3.3
4.0
4.1
2.8
0.0
0.0
2.5
4.4
6.3
133.
60.
00.
01.
75.
27.
9un
know
n0
0.0
00.
00
0
SA
PS
IIsc
ore
≤10
212.
010
11.
20
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
00.
00.
00.
00.
00.
00.
010
-19
868.
156
56.
60
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
00.
00.
00.
00.
00.
00.
020
-29
192
18.1
1420
16.5
31.
60.
00.
01.
82.
62.
72.
10.
00.
02.
03.
25.
33
3.3
0.0
0.0
4.0
6.1
6.7
30-3
920
018
.915
6218
.14
2.0
0.0
0.0
0.0
2.2
5.0
2.6
0.0
0.0
0.0
3.0
5.9
32.
80.
00.
00.
03.
36.
540
-49
137
12.9
1407
16.3
75.
10.
00.
05.
05.
911
.55.
00.
00.
05.
96.
48.
37
6.4
0.0
0.0
7.3
8.7
8.8
50-5
970
6.6
649
7.5
34.
30.
00.
00.
08.
325
.04.
60.
00.
00.
09.
812
.73
5.5
0.0
0.0
0.0
10.4
13.7
≥60
847.
995
511
.12
2.4
0.0
0.0
0.0
2.7
10.0
2.1
0.0
0.0
0.0
2.6
6.4
22.
20.
00.
00.
02.
66.
6un
know
n26
825
.319
5022
.71
0.4
0.0
0.0
0.0
0.0
2.0
0.5
0.0
0.0
0.0
0.0
1.7
00.
00.
00.
00.
00.
00.
0
apa
ts=
patie
nts
patd
ays=
patie
ntda
ysN
B=
Nos
ocom
ialB
acte
rem
ia;C
AB
=C
athe
ter
Ass
ocia
ted
NB
b#=
crud
enu
mbe
r;pa
ts/p
atda
ys%
=pe
rcen
tage
ofto
talp
ats/
patd
ays;
NB
%=
#N
B/1
00pa
tient
s;N
Bin
cd=
#N
B/1
000
patie
ntda
ys;C
AB
incd
=#
NP
/100
0C
athe
ter
days
(bef
ore
1stN
B);
Scientific Institute Public Health, Brussels, 12 Nov 2015 12:26:12 19
Surveillance of ICU-acquired InfectionsNational Feedback Report Risk Factor Indicators Year 2013
Tabl
e20
:B
lood
stre
amIn
fect
ion
and
Adm
issi
onE
xpos
ure
(b)
pats
apa
tday
saN
Ba
CA
Ba
#b%
b#b
%b
#b%
bin
cdb
#bin
cdb
agg
agg
agg
agg
agg
agg
p10
p25
p50
p75
p90
agg
p10
p25
p50
p75
p90
agg
agg
p10
p25
p50
p75
p90
AP
AC
HE
sco
re<
108
0.8
250.
30
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
00.
00.
00.
00.
00.
00.
010
-19
151.
416
82.
01
6.7
6.7
6.7
6.7
6.7
6.7
6.0
6.0
6.0
6.0
6.0
6.0
16.
56.
56.
56.
56.
56.
520
-29
20.
213
0.2
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00
0.0
0.0
0.0
0.0
0.0
0.0
30-3
91
0.1
90.
10
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
00.
00.
00.
00.
00.
00.
040
-49
00.
00
0.0
00
50-5
90
0.0
00.
00
0≥
600
0.0
00.
00
0un
know
n10
3297
.583
9497
.519
1.8
0.0
0.5
2.0
3.2
3.3
2.3
0.0
0.5
1.7
3.8
4.3
173.
00.
00.
01.
74.
65.
2
Pat
ien
tO
rig
inot
her
serv
ice
563
53.2
4813
55.9
142.
50.
00.
01.
24.
04.
42.
90.
00.
01.
84.
44.
912
3.2
0.0
0.0
1.3
4.9
5.6
othe
rIC
U2
0.2
140.
20
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
00.
00.
00.
00.
00.
00.
0co
mm
unity
437
41.3
3438
39.9
61.
40.
00.
00.
02.
38.
11.
70.
00.
00.
02.
78.
26
3.0
0.0
0.0
0.0
3.7
10.2
nurs
ing
hom
e53
5.0
326
3.8
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00
0.0
0.0
0.0
0.0
0.0
0.0
unkn
own
30.
318
0.2
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00
0.0
0.0
0.0
0.0
0.0
0.0
Typ
eo
fA
dm
issi
on
med
ical
736
69.6
5859
68.1
111.
50.
00.
01.
63.
87.
81.
90.
00.
02.
33.
96.
59
2.5
0.0
0.0
0.0
3.4
7.4
sche
dule
dsu
rgi-
cal
218
20.6
1475
17.1
31.
40.
00.
00.
02.
33.
12.
00.
00.
00.
03.
43.
73
2.3
0.0
0.0
0.9
4.0
4.0
unsc
hedu
led
surg
ical
989.
312
3314
.36
6.1
0.0
0.0
0.0
14.3
15.0
4.9
0.0
0.0
0.0
10.0
13.5
66.
20.
00.
00.
011
.015
.4
unkn
own
60.
642
0.5
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00
0.0
0.0
0.0
0.0
0.0
0.0
apa
ts=
patie
nts
patd
ays=
patie
ntda
ysN
B=
Nos
ocom
ialB
acte
rem
ia;C
AB
=C
athe
ter
Ass
ocia
ted
NB
b#=
crud
enu
mbe
r;pa
ts/p
atda
ys%
=pe
rcen
tage
ofto
talp
ats/
patd
ays;
NB
%=
#N
B/1
00pa
tient
s;N
Bin
cd=
#N
B/1
000
patie
ntda
ys;C
AB
incd
=#
NP
/100
0C
athe
ter
days
(bef
ore
1stN
B);
Scientific Institute Public Health, Brussels, 12 Nov 2015 12:26:12 20
Surveillance of ICU-acquired InfectionsNational Feedback Report Risk Factor Indicators Year 2013
Tabl
e21
:B
lood
stre
amIn
fect
ion
and
Adm
issi
onE
xpos
ure
(c)
pats
apa
tday
saN
Ba
CA
Ba
#b%
b#b
%b
#b%
bin
cdb
#bin
cdb
agg
agg
agg
agg
agg
agg
p10
p25
p50
p75
p90
agg
p10
p25
p50
p75
p90
agg
agg
p10
p25
p50
p75
p90
Trau
ma
no82
477
.965
3075
.912
1.5
0.0
0.0
1.2
2.5
3.3
1.8
0.0
0.0
1.4
2.6
3.9
102.
40.
00.
00.
63.
14.
7ye
s76
7.2
822
9.5
33.
90.
00.
00.
05.
020
.03.
60.
00.
00.
06.
914
.33
5.7
0.0
0.0
0.0
9.5
18.2
unkn
own
158
14.9
1257
14.6
53.
20.
00.
00.
00.
03.
34.
00.
00.
00.
00.
04.
15
4.4
0.0
0.0
0.0
2.3
4.5
Imp
aire
dIm
mu
nit
yno
806
76.2
6432
74.7
111.
40.
00.
00.
62.
82.
91.
70.
00.
00.
73.
24.
210
2.5
0.0
0.0
1.4
3.7
5.2
yes
969.
184
19.
84
4.2
0.0
0.0
2.9
7.4
10.0
4.8
0.0
0.0
2.6
8.3
13.9
34.
60.
00.
00.
05.
611
.6un
know
n15
614
.713
3615
.55
3.2
0.0
0.0
0.0
0.0
3.3
3.7
0.0
0.0
0.0
0.0
3.8
54.
20.
00.
00.
02.
14.
3
An
tib
ioti
cTr
eatm
ent
no44
141
.731
2536
.36
1.4
0.0
0.0
0.0
1.9
3.2
1.9
0.0
0.0
0.0
2.4
4.5
63.
20.
00.
00.
03.
55.
5ye
s57
053
.951
0759
.313
2.3
0.0
0.0
2.2
3.4
4.4
2.5
0.0
0.0
1.7
4.0
4.6
112.
90.
00.
02.
04.
55.
3un
know
n47
4.4
377
4.4
12.
10.
00.
00.
00.
03.
72.
70.
00.
00.
00.
03.
41
3.6
0.0
0.0
0.0
3.8
3.8
apa
ts=
patie
nts
patd
ays=
patie
ntda
ysN
B=
Nos
ocom
ialB
acte
rem
ia;C
AB
=C
athe
ter
Ass
ocia
ted
NB
b#=
crud
enu
mbe
r;pa
ts/p
atda
ys%
=pe
rcen
tage
ofto
talp
ats/
patd
ays;
NB
%=
#N
B/1
00pa
tient
s;N
Bin
cd=
#N
B/1
000
patie
ntda
ys;C
AB
incd
=#
NP
/100
0C
athe
ter
days
(bef
ore
1stN
B);
Scientific Institute Public Health, Brussels, 12 Nov 2015 12:26:12 21
Surveillance of ICU-acquired InfectionsNational Feedback Report Risk Factor Indicators Year 2013
Tabl
e22
:B
lood
stre
amIn
fect
ion
and
Adm
issi
onE
xpos
ure
(d)
pats
apa
tday
saN
Ba
CA
Ba
#b%
b#b
%b
#b%
bin
cdb
#bin
cdb
agg
agg
agg
agg
agg
agg
p10
p25
p50
p75
p90
agg
p10
p25
p50
p75
p90
agg
agg
p10
p25
p50
p75
p90
Acu
teC
oro
nar
yC
are
no80
576
.165
7076
.314
1.7
0.0
0.6
1.7
3.2
3.5
2.1
0.0
0.6
1.7
3.6
4.8
122.
80.
00.
01.
74.
35.
8ye
s95
9.0
706
8.2
11.
10.
00.
00.
00.
04.
81.
40.
00.
00.
00.
05.
91
2.2
0.0
0.0
0.0
0.0
8.6
unkn
own
158
14.9
1333
15.5
53.
20.
00.
00.
01.
63.
33.
80.
00.
00.
01.
93.
85
4.2
0.0
0.0
2.1
4.3
4.3
Pri
or
Su
rger
ysi
teno
690
65.2
5373
62.4
101.
40.
00.
01.
53.
78.
51.
90.
00.
02.
33.
96.
88
2.5
0.0
0.0
0.0
3.1
7.7
coro
nary
585.
534
03.
90
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
00.
00.
00.
00.
00.
00.
0ot
her
card
iac
636.
040
54.
71
1.6
0.0
0.0
0.0
0.0
2.2
2.5
0.0
0.0
0.0
0.0
3.1
12.
60.
00.
00.
03.
23.
2ot
her
thor
acic
292.
725
93.
00
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
00.
00.
00.
00.
00.
00.
0ot
her
vasc
ular
292.
733
93.
90
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
00.
00.
00.
00.
00.
00.
0ab
dom
inal
282.
640
74.
73
10.7
0.0
0.0
0.0
7.7
33.3
7.4
0.0
0.0
0.0
8.2
13.2
38.
30.
00.
00.
09.
714
.3ne
uros
urge
ry51
4.8
525
6.1
12.
00.
00.
00.
00.
07.
11.
90.
00.
00.
00.
04.
51
2.7
0.0
0.0
0.0
0.0
5.9
othe
r11
911
.210
0511
.75
4.2
0.0
0.0
0.0
8.3
11.5
5.0
0.0
0.0
0.0
7.4
12.0
55.
90.
00.
00.
08.
314
.2un
know
n0
0.0
00.
00
0
apa
ts=
patie
nts
patd
ays=
patie
ntda
ysN
B=
Nos
ocom
ialB
acte
rem
ia;C
AB
=C
athe
ter
Ass
ocia
ted
NB
b#=
crud
enu
mbe
r;pa
ts/p
atda
ys%
=pe
rcen
tage
ofto
talp
ats/
patd
ays;
NB
%=
#N
B/1
00pa
tient
s;N
Bin
cd=
#N
B/1
000
patie
ntda
ys;C
AB
incd
=#
NP
/100
0C
athe
ter
days
(bef
ore
1stN
B);
Scientific Institute Public Health, Brussels, 12 Nov 2015 12:26:12 22
Surveillance of ICU-acquired InfectionsNational Feedback Report Risk Factor Indicators Year 2013
Tabl
e23
:P
neum
onia
and
Inva
sive
Dev
ice
Exp
osur
e(a
)
pats
apa
tday
saN
Pa
IAP
a
#b%
b#b
%b
#b%
bin
cdb
#bin
cdb
agg
agg
agg
agg
agg
agg
p10
p25
p50
p75
p90
agg
p10
p25
p50
p75
p90
agg
agg
p10
p25
p50
p75
p90
Intu
bat
ion
060
357
.038
2444
.45
0.8
0.0
0.0
0.0
1.9
4.5
1.3
0.0
0.0
0.0
3.8
7.7
00.
00.
00.
00.
00.
00.
01
262
24.8
1741
20.2
186.
90.
00.
05.
914
.814
.810
.30.
00.
06.
615
.727
.615
23.8
0.0
0.0
15.7
40.4
64.5
2/3
105
9.9
1047
12.2
109.
50.
00.
07.
510
.040
.09.
60.
00.
07.
710
.126
.07
11.1
0.0
0.0
4.8
15.6
34.9
4/6
484.
579
49.
24
8.3
0.0
0.0
0.0
22.2
66.7
5.0
0.0
0.0
0.0
14.3
19.8
23.
60.
00.
00.
09.
811
.5>
=7
403.
812
0314
.08
20.0
0.0
0.0
12.5
40.0
42.9
6.7
0.0
0.0
4.9
10.7
12.3
44.
50.
00.
04.
66.
17.
3
Cen
tral
Vas
cula
rC
ath
eter
041
138
.826
6230
.93
0.7
0.0
0.0
0.0
1.2
5.9
1.1
0.0
0.0
0.0
1.5
9.6
00.
00.
00.
00.
00.
00.
01
149
14.1
734
8.5
1812
.10.
00.
09.
733
.341
.724
.50.
00.
022
.230
.379
.413
51.8
0.0
0.0
25.0
142.
917
3.9
2/3
298
28.2
1894
22.0
103.
40.
00.
02.
35.
47.
55.
30.
00.
04.
38.
310
.79
14.4
0.0
0.0
10.8
18.9
30.1
4/6
116
11.0
1267
14.7
54.
30.
00.
00.
06.
721
.43.
90.
00.
00.
06.
414
.32
3.5
0.0
0.0
0.0
8.9
10.9
>=
784
7.9
2052
23.8
910
.70.
00.
08.
330
.033
.34.
40.
00.
04.
38.
510
.74
3.4
0.0
0.0
4.2
5.6
6.5
Uri
nar
yC
ath
eter
037
535
.428
7333
.417
4.5
0.0
0.0
0.0
9.1
10.2
5.9
0.0
0.0
0.0
12.1
15.6
910
.20.
00.
00.
013
.414
2.9
111
911
.255
76.
514
11.8
0.0
0.0
13.0
30.0
33.3
25.1
0.0
0.0
16.5
46.9
66.7
1071
.90.
00.
047
.611
1.1
187.
52/
336
634
.621
8725
.46
1.6
0.0
0.0
0.9
2.2
2.5
2.7
0.0
0.0
1.6
3.6
3.9
59.
00.
00.
04.
514
.516
.74/
610
910
.310
8012
.52
1.8
0.0
0.0
0.0
2.9
7.1
1.9
0.0
0.0
0.0
3.0
6.8
12.
60.
00.
00.
00.
011
.6>
=7
898.
419
1222
.26
6.7
0.0
0.0
5.8
10.0
27.3
3.1
0.0
0.0
3.1
4.1
10.2
32.
90.
00.
01.
85.
66.
0
apa
ts=
patie
nts
patd
ays=
patie
ntda
ysN
P=
Nos
ocom
ialP
neum
onia
;IA
P=
Intu
batio
nA
ssoc
iate
dN
Pb
#=cr
ude
num
ber;
pats
/pat
days
%=
perc
enta
geof
tota
lpat
s/pa
tday
s;N
P%
=#
NP
/100
patie
nts;
NP
incd
=#
NP
/100
0pa
tient
days
;IA
Pin
cd=
#N
P/1
000
intu
batio
nda
ys(b
efor
e1s
tNP
);IU
R=
Intu
batio
nU
tiliz
atio
nR
ate,
intu
batio
nda
ys/1
000
patie
ntda
ys
Scientific Institute Public Health, Brussels, 12 Nov 2015 12:26:12 23
Surveillance of ICU-acquired InfectionsNational Feedback Report Risk Factor Indicators Year 2013
Tabl
e24
:P
neum
onia
and
Inva
sive
Dev
ice
Exp
osur
e(b
)
pats
apa
tday
saN
Pa
IAP
a
#b%
b#b
%b
#b%
bin
cdb
#bin
cdb
agg
agg
agg
agg
agg
agg
p10
p25
p50
p75
p90
agg
p10
p25
p50
p75
p90
agg
agg
p10
p25
p50
p75
p90
Nas
oO
roIn
test
inal
Tub
ew
ith
ou
tfe
edin
g0
629
59.5
4199
48.8
71.
10.
00.
01.
13.
94.
81.
70.
00.
01.
56.
06.
63
3.9
0.0
0.0
0.0
4.3
11.1
126
925
.420
1423
.426
9.7
0.0
0.0
8.3
14.0
20.0
12.9
0.0
0.0
8.8
18.8
20.4
1921
.30.
00.
017
.237
.646
.02/
395
9.0
1061
12.3
55.
30.
00.
05.
97.
112
.54.
70.
00.
03.
27.
112
.53
6.0
0.0
0.0
0.0
7.5
16.7
4/6
403.
857
96.
72
5.0
0.0
0.0
0.0
0.0
18.2
3.5
0.0
0.0
0.0
0.0
12.8
13.
00.
00.
00.
00.
09.
9>
=7
252.
475
68.
85
20.0
0.0
0.0
4.2
33.3
100.
06.
60.
00.
02.
19.
817
.12
4.1
0.0
0.0
0.0
5.3
6.8
Nas
oO
roIn
test
inal
Tub
ew
ith
feed
ing
082
978
.453
3161
.917
2.1
0.0
0.8
2.4
3.8
4.5
3.2
0.0
1.1
2.4
7.6
7.6
98.
00.
00.
06.
011
.114
.41
686.
466
97.
812
17.6
0.0
10.0
13.6
25.0
36.4
17.9
0.0
9.6
13.7
18.5
48.2
1131
.413
.017
.228
.629
.493
.02/
389
8.4
1028
11.9
1011
.20.
00.
00.
025
.066
.79.
70.
00.
00.
011
.426
.76
10.7
0.0
0.0
0.0
9.9
28.2
4/6
454.
378
49.
13
6.7
0.0
0.0
0.0
16.7
33.3
3.8
0.0
0.0
0.0
11.1
12.5
12.
10.
00.
00.
00.
09.
4>
=7
272.
679
79.
33
11.1
0.0
0.0
0.0
40.0
50.0
3.8
0.0
0.0
0.0
8.2
13.9
12.
10.
00.
00.
00.
06.
2
Par
ente
ralN
utr
itio
n0
939
88.8
6633
77.0
333.
50.
00.
02.
86.
58.
55.
00.
00.
03.
69.
912
.021
10.1
0.0
0.0
7.1
14.9
22.9
132
3.0
382
4.4
515
.60.
00.
00.
020
.033
.313
.10.
00.
00.
022
.122
.74
18.8
0.0
0.0
0.0
27.8
33.3
2/3
454.
360
07.
02
4.4
0.0
0.0
0.0
5.3
12.5
3.3
0.0
0.0
0.0
3.5
9.3
15.
30.
00.
00.
00.
014
.74/
626
2.5
398
4.6
13.
80.
00.
00.
00.
010
0.0
2.5
0.0
0.0
0.0
0.0
55.6
00.
00.
00.
00.
00.
00.
0>
=7
161.
559
66.
94
25.0
0.0
0.0
0.0
50.0
66.7
6.7
0.0
0.0
0.0
8.5
13.6
25.
70.
00.
00.
012
.712
.8
apa
ts=
patie
nts
patd
ays=
patie
ntda
ysN
P=
Nos
ocom
ialP
neum
onia
;IA
P=
Intu
batio
nA
ssoc
iate
dN
Pb
#=cr
ude
num
ber;
pats
/pat
days
%=
perc
enta
geof
tota
lpat
s/pa
tday
s;N
P%
=#
NP
/100
patie
nts;
NP
incd
=#
NP
/100
0pa
tient
days
;IA
Pin
cd=
#N
P/1
000
intu
batio
nda
ys(b
efor
e1s
tNP
);IU
R=
Intu
batio
nU
tiliz
atio
nR
ate,
intu
batio
nda
ys/1
000
patie
ntda
ys
Scientific Institute Public Health, Brussels, 12 Nov 2015 12:26:12 24
Surveillance of ICU-acquired InfectionsNational Feedback Report Risk Factor Indicators Year 2013
Tabl
e25
:P
neum
onia
and
Inva
sive
Dev
ice
Exp
osur
e(c
)
pats
apa
tday
saN
Pa
IAP
a
#b%
b#b
%b
#b%
bin
cdb
#bin
cdb
agg
agg
agg
agg
agg
agg
p10
p25
p50
p75
p90
agg
p10
p25
p50
p75
p90
agg
agg
p10
p25
p50
p75
p90
Inva
sive
Mec
han
ical
Ven
tila
tio
n0
668
63.1
4469
51.9
101.
50.
00.
00.
74.
14.
52.
20.
00.
01.
05.
57.
33
4.0
0.0
0.0
0.0
0.0
6.9
122
221
.015
2817
.716
7.2
0.0
0.0
5.9
14.3
14.8
10.5
0.0
0.0
8.6
15.9
26.8
1324
.30.
00.
016
.643
.064
.52/
399
9.4
1032
12.0
1212
.10.
00.
08.
19.
150
.011
.60.
00.
08.
19.
227
.68
12.6
0.0
0.0
8.9
13.1
32.8
4/6
424.
070
88.
22
4.8
0.0
0.0
0.0
0.0
66.7
2.8
0.0
0.0
0.0
0.0
19.8
12.
00.
00.
00.
00.
011
.5>
=7
272.
687
210
.15
18.5
0.0
0.0
18.8
40.0
50.0
5.7
0.0
0.0
6.3
8.2
23.8
35.
30.
00.
03.
18.
19.
8
No
n-I
nva
sive
Mec
han
ical
Ven
tila
tio
n0
949
89.7
7353
85.4
373.
90.
02.
23.
47.
08.
45.
00.
01.
83.
99.
312
.022
8.7
0.0
3.0
6.9
12.8
12.8
179
7.5
892
10.4
810
.10.
00.
02.
516
.733
.39.
00.
00.
02.
514
.825
.66
17.2
0.0
0.0
5.1
16.9
87.0
2/3
222.
121
32.
50
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
00.
00.
00.
00.
00.
00.
04/
65
0.5
941.
10
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
00.
00.
00.
00.
00.
00.
0>
=7
30.
357
0.7
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00
0.0
0.0
0.0
0.0
0.0
0.0
Trac
heo
tom
yIn
tub
atio
n0
1034
97.7
8083
93.9
414.
00.
00.
02.
58.
110
.25.
10.
00.
03.
011
.212
.124
9.0
0.0
0.0
6.9
13.4
22.8
14
0.4
851.
02
50.0
0.0
0.0
50.0
100.
010
0.0
23.5
0.0
0.0
27.0
37.0
37.0
237
.00.
00.
037
.083
.383
.32/
37
0.7
831.
02
28.6
0.0
0.0
33.3
50.0
50.0
24.1
0.0
0.0
24.4
30.3
30.3
229
.025
.625
.629
.533
.333
.34/
65
0.5
851.
00
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
00.
00.
00.
00.
00.
00.
0>
=7
80.
827
33.
20
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
00.
00.
00.
00.
00.
00.
0
apa
ts=
patie
nts
patd
ays=
patie
ntda
ysN
P=
Nos
ocom
ialP
neum
onia
;IA
P=
Intu
batio
nA
ssoc
iate
dN
Pb
#=cr
ude
num
ber;
pats
/pat
days
%=
perc
enta
geof
tota
lpat
s/pa
tday
s;N
P%
=#
NP
/100
patie
nts;
NP
incd
=#
NP
/100
0pa
tient
days
;IA
Pin
cd=
#N
P/1
000
intu
batio
nda
ys(b
efor
e1s
tNP
);IU
R=
Intu
batio
nU
tiliz
atio
nR
ate,
intu
batio
nda
ys/1
000
patie
ntda
ys
Scientific Institute Public Health, Brussels, 12 Nov 2015 12:26:12 25
Surveillance of ICU-acquired InfectionsNational Feedback Report Risk Factor Indicators Year 2013
Tabl
e26
:B
lood
stre
amIn
fect
ion
and
Inva
sive
Dev
ice
Exp
osur
e(a
)
pats
apa
tday
saN
Ba
CA
Ba
#b%
b#b
%b
#b%
bin
cdb
#bin
cdb
agg
agg
agg
agg
agg
agg
p10
p25
p50
p75
p90
agg
p10
p25
p50
p75
p90
agg
agg
p10
p25
p50
p75
p90
Intu
bat
ion
062
859
.442
6149
.55
0.8
0.0
0.0
0.0
1.7
2.1
1.2
0.0
0.0
0.0
2.9
3.0
52.
40.
00.
00.
04.
45.
21
247
23.3
1524
17.7
31.
20.
00.
00.
02.
44.
02.
00.
00.
00.
04.
44.
83
2.3
0.0
0.0
0.0
4.9
6.3
2/3
999.
493
610
.94
4.0
0.0
0.0
2.6
10.0
14.3
4.3
0.0
0.0
2.8
8.3
16.7
33.
60.
00.
00.
08.
517
.24/
647
4.4
778
9.0
36.
40.
00.
00.
050
.050
.03.
90.
00.
00.
012
.343
.52
2.8
0.0
0.0
0.0
5.1
12.3
>=
737
3.5
1110
12.9
513
.50.
00.
00.
033
.333
.34.
50.
00.
00.
07.
210
.75
5.1
0.0
0.0
0.0
7.6
10.7
Cen
tral
Vas
cula
rC
ath
eter
043
340
.930
6035
.50
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
00.
00.
00.
00.
00.
00.
01
134
12.7
539
6.3
32.
20.
00.
00.
02.
918
.25.
60.
00.
00.
07.
923
.83
7.1
0.0
0.0
0.0
8.2
40.0
2/3
295
27.9
1795
20.9
72.
40.
00.
02.
03.
06.
53.
90.
00.
03.
54.
69.
27
4.2
0.0
0.0
3.6
5.3
9.5
4/6
114
10.8
1209
14.0
32.
60.
00.
00.
014
.315
.42.
50.
00.
00.
010
.813
.22
1.7
0.0
0.0
0.0
0.0
10.8
>=
782
7.8
2006
23.3
78.
50.
00.
05.
315
.025
.03.
50.
00.
02.
56.
26.
56
3.3
0.0
0.0
2.9
4.9
6.8
Uri
nar
yC
ath
eter
038
836
.730
3035
.25
1.3
0.0
0.0
0.0
0.0
3.2
1.7
0.0
0.0
0.0
0.0
3.8
52.
60.
00.
00.
00.
04.
21
108
10.2
442
5.1
32.
80.
00.
00.
02.
422
.26.
80.
00.
00.
06.
826
.03
13.1
0.0
0.0
0.0
8.4
31.3
2/3
366
34.6
2179
25.3
61.
60.
00.
00.
92.
55.
42.
80.
00.
01.
64.
18.
06
4.5
0.0
0.0
2.2
6.1
9.4
4/6
108
10.2
1046
12.2
10.
90.
00.
00.
00.
014
.31.
00.
00.
00.
00.
013
.30
0.0
0.0
0.0
0.0
0.0
0.0
>=
788
8.3
1912
22.2
55.
70.
00.
01.
911
.114
.32.
60.
00.
01.
04.
46.
04
2.5
0.0
0.0
1.3
4.6
4.9
apa
ts=
patie
nts
patd
ays=
patie
ntda
ysN
B=
Nos
ocom
ialB
acte
rem
ia;C
AB
=C
athe
ter
Ass
ocia
ted
NB
b#=
crud
enu
mbe
r;pa
ts/p
atda
ys%
=pe
rcen
tage
ofto
talp
ats/
patd
ays;
NB
%=
#N
B/1
00pa
tient
s;N
Bin
cd=
#N
B/1
000
patie
ntda
ys;C
AB
incd
=#
NP
/100
0C
athe
ter
days
(bef
ore
1stN
B);
Scientific Institute Public Health, Brussels, 12 Nov 2015 12:26:12 26
Surveillance of ICU-acquired InfectionsNational Feedback Report Risk Factor Indicators Year 2013
Tabl
e27
:B
lood
stre
amIn
fect
ion
and
Inva
sive
Dev
ice
Exp
osur
e(b
)
pats
apa
tday
saN
Ba
CA
Ba
#b%
b#b
%b
#b%
bin
cdb
#bin
cdb
agg
agg
agg
agg
agg
agg
p10
p25
p50
p75
p90
agg
p10
p25
p50
p75
p90
agg
agg
p10
p25
p50
p75
p90
Nas
oO
roIn
test
inal
Tub
ew
ith
ou
tfe
edin
g0
654
61.8
4682
54.4
71.
10.
00.
01.
73.
03.
81.
50.
00.
02.
22.
93.
55
2.0
0.0
0.0
0.0
4.4
4.5
124
823
.416
2718
.95
2.0
0.0
0.0
0.0
2.8
6.4
3.1
0.0
0.0
0.0
6.1
6.4
53.
60.
00.
00.
06.
18.
42/
394
8.9
1050
12.2
44.
30.
00.
00.
07.
722
.23.
80.
00.
00.
07.
213
.04
4.2
0.0
0.0
0.0
7.7
13.5
4/6
393.
759
46.
91
2.6
0.0
0.0
0.0
0.0
50.0
1.7
0.0
0.0
0.0
0.0
8.9
11.
90.
00.
00.
00.
09.
1>
=7
232.
265
67.
63
13.0
0.0
0.0
4.2
20.0
100.
04.
60.
00.
01.
96.
127
.83
5.4
0.0
0.0
2.1
6.5
27.8
Nas
oO
roIn
test
inal
Tub
ew
ith
feed
ing
084
579
.956
8466
.08
0.9
0.0
0.0
0.0
1.9
3.1
1.4
0.0
0.0
0.0
3.5
4.4
82.
30.
00.
00.
04.
57.
21
595.
649
55.
73
5.1
0.0
0.0
6.3
14.3
14.3
6.1
0.0
0.0
5.2
15.6
16.7
37.
30.
00.
011
.216
.917
.22/
383
7.8
839
9.7
44.
80.
00.
00.
014
.320
.04.
80.
00.
00.
07.
619
.63
4.3
0.0
0.0
0.0
5.6
7.6
4/6
424.
068
98.
00
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
00.
00.
00.
00.
00.
00.
0>
=7
292.
790
210
.55
17.2
0.0
0.0
7.7
40.0
50.0
5.5
0.0
0.0
3.0
8.1
8.5
45.
00.
00.
01.
88.
59.
3
Par
ente
ralN
utr
itio
n0
940
88.8
6713
78.0
91.
00.
00.
00.
71.
92.
31.
30.
00.
01.
02.
93.
18
1.9
0.0
0.0
1.2
3.5
3.9
132
3.0
335
3.9
515
.60.
00.
00.
040
.050
.014
.90.
00.
00.
030
.858
.84
14.0
0.0
0.0
0.0
18.3
32.8
2/3
484.
573
08.
55
10.4
0.0
0.0
5.3
16.7
40.0
6.8
0.0
0.0
4.8
9.7
10.6
57.
50.
00.
05.
910
.011
.24/
625
2.4
380
4.4
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00
0.0
0.0
0.0
0.0
0.0
0.0
>=
713
1.2
451
5.2
17.
70.
00.
00.
00.
050
.02.
20.
00.
00.
00.
08.
51
2.7
0.0
0.0
0.0
0.0
9.3
apa
ts=
patie
nts
patd
ays=
patie
ntda
ysN
B=
Nos
ocom
ialB
acte
rem
ia;C
AB
=C
athe
ter
Ass
ocia
ted
NB
b#=
crud
enu
mbe
r;pa
ts/p
atda
ys%
=pe
rcen
tage
ofto
talp
ats/
patd
ays;
NB
%=
#N
B/1
00pa
tient
s;N
Bin
cd=
#N
B/1
000
patie
ntda
ys;C
AB
incd
=#
NP
/100
0C
athe
ter
days
(bef
ore
1stN
B);
Scientific Institute Public Health, Brussels, 12 Nov 2015 12:26:12 27
Surveillance of ICU-acquired InfectionsNational Feedback Report Risk Factor Indicators Year 2013
Tabl
e28
:B
lood
stre
amIn
fect
ion
and
Inva
sive
Dev
ice
Exp
osur
e(c
)
pats
apa
tday
saN
Ba
CA
Ba
#b%
b#b
%b
#b%
bin
cdb
#bin
cdb
agg
agg
agg
agg
agg
agg
p10
p25
p50
p75
p90
agg
p10
p25
p50
p75
p90
agg
agg
p10
p25
p50
p75
p90
Inva
sive
Mec
han
ical
Ven
tila
tio
n0
691
65.3
4871
56.6
81.
20.
00.
00.
02.
13.
31.
60.
00.
00.
03.
14.
48
3.0
0.0
0.0
0.0
5.2
5.3
120
819
.713
1915
.32
1.0
0.0
0.0
0.0
0.0
3.9
1.5
0.0
0.0
0.0
0.0
4.4
21.
90.
00.
00.
00.
06.
22/
389
8.4
780
9.1
22.
20.
00.
00.
09.
114
.32.
60.
00.
00.
07.
316
.72
2.8
0.0
0.0
0.0
7.6
17.2
4/6
444.
277
39.
04
9.1
0.0
0.0
7.5
20.0
50.0
5.2
0.0
0.0
4.5
12.3
13.9
22.
90.
00.
00.
04.
612
.3>
=7
262.
586
610
.14
15.4
0.0
0.0
0.0
28.6
40.0
4.6
0.0
0.0
0.0
8.1
8.4
45.
30.
00.
00.
08.
59.
5
No
n-I
nva
sive
Mec
han
ical
Ven
tila
tio
n0
953
90.1
7497
87.1
161.
70.
00.
52.
13.
13.
32.
10.
00.
61.
83.
74.
414
2.7
0.0
0.0
1.7
4.2
5.2
174
7.0
712
8.3
34.
10.
00.
00.
02.
620
.04.
20.
00.
00.
03.
110
.73
6.0
0.0
0.0
0.0
4.6
12.1
2/3
232.
224
92.
91
4.3
0.0
0.0
0.0
0.0
8.3
4.0
0.0
0.0
0.0
0.0
8.5
16.
80.
00.
00.
012
.212
.24/
65
0.5
941.
10
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
00.
00.
00.
00.
00.
00.
0>
=7
30.
357
0.7
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00
0.0
0.0
0.0
0.0
0.0
0.0
Trac
heo
tom
yIn
tub
atio
n0
1037
98.0
8146
94.6
191.
80.
00.
52.
23.
23.
32.
30.
00.
62.
23.
84.
418
3.2
0.0
0.0
1.7
4.9
5.2
12
0.2
310.
40
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
00.
00.
00.
00.
00.
00.
02/
35
0.5
470.
50
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
00.
00.
00.
00.
00.
00.
04/
65
0.5
851.
00
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
00.
00.
00.
00.
00.
00.
0>
=7
90.
930
03.
51
11.1
0.0
0.0
0.0
16.7
33.3
3.3
0.0
0.0
0.0
5.0
10.0
00.
00.
00.
00.
00.
00.
0
apa
ts=
patie
nts
patd
ays=
patie
ntda
ysN
B=
Nos
ocom
ialB
acte
rem
ia;C
AB
=C
athe
ter
Ass
ocia
ted
NB
b#=
crud
enu
mbe
r;pa
ts/p
atda
ys%
=pe
rcen
tage
ofto
talp
ats/
patd
ays;
NB
%=
#N
B/1
00pa
tient
s;N
Bin
cd=
#N
B/1
000
patie
ntda
ys;C
AB
incd
=#
NP
/100
0C
athe
ter
days
(bef
ore
1stN
B);
Scientific Institute Public Health, Brussels, 12 Nov 2015 12:26:12 28
Surveillance of ICU-acquired InfectionsNational Feedback Report Risk Factor Indicators Year 2013
Tabl
e29
:P
neum
onia
and
SO
FAsc
ore
(a)
pats
apa
tday
saN
Pa
IAP
a
#b%
b#b
%b
#b%
bin
cdb
#bin
cdb
agg
agg
agg
agg
agg
agg
p10
p25
p50
p75
p90
agg
p10
p25
p50
p75
p90
agg
agg
p10
p25
p50
p75
p90
mea
nC
NS
SO
FAsc
ore
016
24.
912
595.
33
1.9
1.4
1.4
2.9
4.3
4.3
2.4
1.8
1.8
4.8
7.8
7.8
14.
14.
14.
14.
14.
14.
10.
1/1
993.
076
73.
25
5.1
4.6
4.6
5.2
5.9
5.9
6.5
5.5
5.5
7.3
9.2
9.2
29.
80.
00.
05.
110
.210
.21.
1/2
521.
638
71.
61
1.9
0.0
0.0
1.6
3.2
3.2
2.6
0.0
0.0
2.2
4.4
4.4
17.
00.
00.
05.
711
.511
.52.
1/3
230.
728
11.
24
17.4
11.1
11.1
16.3
21.4
21.4
14.2
9.3
9.3
13.3
17.3
17.3
323
.122
.522
.523
.424
.424
.43.
1/4
200.
615
20.
63
15.0
11.1
11.1
14.6
18.2
18.2
19.7
17.5
17.5
19.3
21.1
21.1
217
.40.
00.
013
.727
.427
.4
mea
nR
esp
irat
ory
SO
FAsc
ore
011
0.3
530.
20
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
00.
00.
00.
00.
00.
00.
00.
1/1
511.
529
61.
20
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
00.
00.
00.
00.
00.
00.
01.
1/2
100
3.0
808
3.4
66.
03.
53.
512
.521
.421
.47.
44.
44.
414
.424
.424
.43
14.9
7.5
7.5
18.3
29.0
29.0
2.1/
311
43.
412
475.
24
3.5
3.2
3.2
4.2
5.3
5.3
3.2
2.8
2.8
4.2
5.7
5.7
36.
15.
05.
08.
411
.811
.83.
1/4
230.
721
70.
94
17.4
16.7
16.7
18.3
20.0
20.0
18.4
17.3
17.3
20.0
22.7
22.7
325
.420
.820
.833
.145
.545
.5
mea
nC
oag
ula
tio
nS
OFA
sco
re0
217
6.5
1703
7.2
94.
13.
23.
25.
06.
86.
85.
33.
83.
87.
010
.210
.24
9.8
6.2
6.2
14.5
22.7
22.7
0.1/
181
2.4
780
3.3
56.
24.
44.
46.
48.
38.
36.
44.
24.
27.
09.
79.
74
13.7
13.2
13.2
13.7
14.3
14.3
1.1/
238
1.1
302
1.3
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00
0.0
0.0
0.0
0.0
0.0
0.0
2.1/
318
0.5
139
0.6
211
.10.
00.
020
.040
.040
.014
.40.
00.
025
.050
.050
.01
21.3
0.0
0.0
41.7
83.3
83.3
3.1/
43
0.1
250.
10
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
00.
00.
00.
00.
00.
00.
0
apa
ts=
patie
nts
patd
ays=
patie
ntda
ysN
P=
Nos
ocom
ialP
neum
onia
;IA
P=
Intu
batio
nA
ssoc
iate
dN
Pb
#=cr
ude
num
ber;
pats
/pat
days
%=
perc
enta
geof
tota
lpat
s/pa
tday
s;N
P%
=#
NP
/100
patie
nts;
NP
incd
=#
NP
/100
0pa
tient
days
;IA
Pin
cd=
#N
P/1
000
intu
batio
nda
ys(b
efor
e1s
tNP
);
Scientific Institute Public Health, Brussels, 12 Nov 2015 12:26:12 29
Surveillance of ICU-acquired InfectionsNational Feedback Report Risk Factor Indicators Year 2013
Tabl
e30
:P
neum
onia
and
SO
FAsc
ore
(b)
pats
apa
tday
saN
Pa
IAP
a
#b%
b#b
%b
#b%
bin
cdb
#bin
cdb
agg
agg
agg
agg
agg
agg
p10
p25
p50
p75
p90
agg
p10
p25
p50
p75
p90
agg
agg
p10
p25
p50
p75
p90
mea
nC
ard
iova
scu
lar
SO
FAsc
ore
012
93.
983
83.
53
2.3
0.9
0.9
5.7
10.5
10.5
3.6
1.4
1.4
9.8
18.2
18.2
18.
00.
00.
04.
58.
98.
90.
1/1
133
4.0
1112
4.7
43.
02.
92.
93.
03.
13.
13.
62.
82.
83.
94.
94.
92
5.9
0.0
0.0
12.0
24.1
24.1
1.1/
260
1.8
650
2.7
46.
74.
84.
87.
911
.111
.16.
24.
64.
66.
99.
29.
22
8.0
6.5
6.5
8.5
10.4
10.4
2.1/
326
0.8
205
0.9
311
.55.
65.
615
.325
.025
.014
.67.
27.
218
.730
.330
.32
23.5
23.3
23.3
23.5
23.8
23.8
3.1/
48
0.2
650.
32
25.0
25.0
25.0
25.0
25.0
25.0
30.8
26.3
26.3
31.7
37.0
37.0
247
.645
.545
.547
.750
.050
.0
mea
nR
enal
SO
FAsc
ore
014
94.
512
535.
37
4.7
4.2
4.2
4.9
5.7
5.7
5.6
4.4
4.4
6.7
9.0
9.0
412
.29.
19.
113
.818
.518
.50.
1/1
932.
874
43.
12
2.2
0.0
0.0
3.4
6.9
6.9
2.7
0.0
0.0
4.1
8.2
8.2
210
.30.
00.
016
.733
.333
.31.
1/2
531.
643
61.
84
7.5
5.9
5.9
8.2
10.5
10.5
9.2
7.4
7.4
9.8
12.2
12.2
215
.012
.512
.515
.718
.918
.92.
1/3
331.
030
31.
32
6.1
0.0
0.0
11.1
22.2
22.2
6.6
0.0
0.0
11.9
23.8
23.8
00.
00.
00.
00.
00.
00.
03.
1/4
290.
923
51.
01
3.4
0.0
0.0
1.9
3.8
3.8
4.3
0.0
0.0
2.3
4.5
4.5
110
.510
.510
.510
.510
.510
.5
mea
nL
iver
SO
FAsc
ore
021
16.
318
777.
913
6.2
3.8
3.8
8.3
12.7
12.7
6.9
4.3
4.3
9.6
14.9
14.9
815
.28.
68.
618
.628
.628
.60.
1/1
752.
363
92.
71
1.3
0.0
0.0
0.8
1.6
1.6
1.6
0.0
0.0
0.9
1.9
1.9
14.
30.
00.
02.
65.
25.
21.
1/2
180.
512
30.
50
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
00.
00.
00.
00.
00.
00.
02.
1/3
70.
248
0.2
114
.30.
00.
050
.010
0.0
100.
020
.80.
00.
071
.414
2.9
142.
90
0.0
0.0
0.0
0.0
0.0
0.0
3.1/
46
0.2
440.
20
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
00.
00.
00.
00.
00.
00.
0
mea
nTo
talS
OFA
sco
re0/
119
0.6
181
0.8
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00
0.0
0.0
0.0
0.0
0.0
0.0
239
1.2
348
1.5
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00
0.0
0.0
0.0
0.0
0.0
0.0
3/4
792.
462
62.
62
2.5
2.5
2.5
2.5
2.5
2.5
3.2
3.2
3.2
3.2
3.2
3.2
16.
76.
76.
76.
76.
76.
75/
657
1.7
545
2.3
35.
33.
83.
814
.425
.025
.05.
54.
04.
011
.819
.619
.61
5.0
0.0
0.0
3.1
6.1
6.1
7/m
ax84
2.5
812
3.4
910
.75.
65.
612
.820
.020
.011
.16.
26.
212
.218
.218
.27
17.8
9.6
9.6
18.2
26.9
26.9
apa
ts=
patie
nts
patd
ays=
patie
ntda
ysN
P=
Nos
ocom
ialP
neum
onia
;IA
P=
Intu
batio
nA
ssoc
iate
dN
Pb
#=cr
ude
num
ber;
pats
/pat
days
%=
perc
enta
geof
tota
lpat
s/pa
tday
s;N
P%
=#
NP
/100
patie
nts;
NP
incd
=#
NP
/100
0pa
tient
days
;IA
Pin
cd=
#N
P/1
000
intu
batio
nda
ys(b
efor
e1s
tNP
);
Scientific Institute Public Health, Brussels, 12 Nov 2015 12:26:12 30
Surveillance of ICU-acquired InfectionsNational Feedback Report Risk Factor Indicators Year 2013
Tabl
e31
:B
lood
stre
amIn
fect
ions
and
SO
FAsc
ore
(a)
pats
apa
tday
saN
Ba
CA
Ba
#b%
b#b
%b
#b%
bin
cdb
#bin
cdb
agg
agg
agg
agg
agg
agg
p10
p25
p50
p75
p90
agg
p10
p25
p50
p75
p90
agg
agg
p10
p25
p50
p75
p90
mea
nC
NS
SO
FAsc
ore
016
34.
913
365.
66
3.7
0.0
0.0
2.1
4.3
4.3
4.5
0.0
0.0
2.5
5.0
5.0
66.
80.
00.
03.
77.
37.
30.
1/1
982.
976
03.
21
1.0
0.0
0.0
0.8
1.5
1.5
1.3
0.0
0.0
0.9
1.8
1.8
11.
80.
00.
01.
22.
32.
31.
1/2
541.
641
21.
70
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
00.
00.
00.
00.
00.
00.
02.
1/3
230.
727
81.
21
4.3
0.0
0.0
5.6
11.1
11.1
3.6
0.0
0.0
4.6
9.3
9.3
00.
00.
00.
00.
00.
00.
03.
1/4
190.
613
70.
61
5.3
0.0
0.0
4.5
9.1
9.1
7.3
0.0
0.0
5.3
10.5
10.5
17.
60.
00.
05.
310
.610
.6
mea
nR
esp
irat
ory
SO
FAsc
ore
011
0.3
530.
20
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
00.
00.
00.
00.
00.
00.
00.
1/1
511.
529
61.
21
2.0
0.0
0.0
1.0
2.0
2.0
3.4
0.0
0.0
1.7
3.5
3.5
15.
20.
00.
02.
75.
55.
51.
1/2
100
3.0
811
3.4
44.
03.
53.
55.
37.
17.
14.
94.
44.
46.
28.
18.
13
5.2
4.4
4.4
6.4
8.5
8.5
2.1/
311
43.
412
205.
13
2.6
0.0
0.0
1.6
3.2
3.2
2.5
0.0
0.0
1.4
2.9
2.9
33.
20.
00.
01.
93.
83.
83.
1/4
230.
724
11.
01
4.3
0.0
0.0
10.0
20.0
20.0
4.1
0.0
0.0
7.4
14.7
14.7
15.
20.
00.
08.
817
.517
.5
mea
nC
oag
ula
tio
nS
OFA
sco
re0
218
6.6
1730
7.3
83.
71.
71.
73.
04.
44.
44.
62.
62.
63.
95.
25.
27
6.2
3.6
3.6
5.3
7.0
7.0
0.1/
180
2.4
753
3.2
11.
30.
00.
01.
12.
32.
31.
30.
00.
01.
12.
32.
31
1.6
0.0
0.0
1.3
2.6
2.6
1.1/
238
1.1
302
1.3
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00
0.0
0.0
0.0
0.0
0.0
0.0
2.1/
318
0.5
139
0.6
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00
0.0
0.0
0.0
0.0
0.0
0.0
3.1/
43
0.1
250.
10
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
00.
00.
00.
00.
00.
00.
0
apa
ts=
patie
nts
patd
ays=
patie
ntda
ysN
B=
Nos
ocom
ialB
acte
rem
ia;C
AB
=C
athe
ter
Ass
ocia
ted
NB
b#=
crud
enu
mbe
r;pa
ts/p
atda
ys%
=pe
rcen
tage
ofto
talp
ats/
patd
ays;
NB
%=
#N
B/1
00pa
tient
s;N
Bin
cd=
#N
B/1
000
patie
ntda
ys;C
AB
incd
=#
NP
/100
0C
athe
ter
days
(bef
ore
1stN
B);
Scientific Institute Public Health, Brussels, 12 Nov 2015 12:26:12 31
Surveillance of ICU-acquired InfectionsNational Feedback Report Risk Factor Indicators Year 2013
Tabl
e32
:B
lood
stre
amIn
fect
ions
and
SO
FAsc
ore
(b)
pats
apa
tday
saN
Ba
CA
Ba
#b%
b#b
%b
#b%
bin
cdb
#bin
cdb
agg
agg
agg
agg
agg
agg
p10
p25
p50
p75
p90
agg
p10
p25
p50
p75
p90
agg
agg
p10
p25
p50
p75
p90
mea
nC
ard
iova
scu
lar
SO
FAsc
ore
012
93.
990
33.
84
3.1
0.0
0.0
1.8
3.6
3.6
4.4
0.0
0.0
2.5
4.9
4.9
36.
70.
00.
03.
87.
67.
60.
1/1
136
4.1
1225
5.2
21.
50.
00.
01.
42.
92.
91.
60.
00.
01.
32.
62.
62
2.2
0.0
0.0
1.6
3.1
3.1
1.1/
260
1.8
565
2.4
23.
30.
00.
02.
34.
54.
53.
50.
00.
02.
75.
35.
32
3.9
0.0
0.0
3.0
6.0
6.0
2.1/
324
0.7
189
0.8
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00
0.0
0.0
0.0
0.0
0.0
0.0
3.1/
48
0.2
650.
31
12.5
0.0
0.0
10.0
20.0
20.0
15.4
0.0
0.0
11.1
22.2
22.2
115
.40.
00.
011
.122
.222
.2
mea
nR
enal
SO
FAsc
ore
014
74.
412
335.
25
3.4
1.9
1.9
3.1
4.2
4.2
4.1
3.0
3.0
3.7
4.4
4.4
45.
45.
25.
25.
45.
55.
50.
1/1
952.
974
33.
12
2.1
0.0
0.0
1.5
3.1
3.1
2.7
0.0
0.0
2.0
4.0
4.0
23.
60.
00.
02.
85.
65.
61.
1/2
531.
645
11.
92
3.8
0.0
0.0
3.0
6.1
6.1
4.4
0.0
0.0
3.6
7.3
7.3
25.
90.
00.
05.
09.
99.
92.
1/3
331.
030
91.
30
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
00.
00.
00.
00.
00.
00.
03.
1/4
290.
923
51.
00
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
00.
00.
00.
00.
00.
00.
0
mea
nL
iver
SO
FAsc
ore
021
06.
318
697.
97
3.3
1.9
1.9
2.8
3.8
3.8
3.7
2.2
2.2
3.2
4.3
4.3
64.
83.
03.
04.
25.
45.
40.
1/1
762.
366
62.
82
2.6
0.0
0.0
1.6
3.1
3.1
3.0
0.0
0.0
1.8
3.6
3.6
23.
60.
00.
02.
24.
44.
41.
1/2
190.
613
10.
60
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
00.
00.
00.
00.
00.
00.
02.
1/3
70.
248
0.2
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00
0.0
0.0
0.0
0.0
0.0
0.0
3.1/
46
0.2
440.
20
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
00.
00.
00.
00.
00.
00.
0
mea
nTo
talS
OFA
sco
re0/
119
0.6
109
0.5
15.
35.
35.
35.
35.
35.
39.
29.
29.
29.
29.
29.
21
21.3
21.3
21.3
21.3
21.3
21.3
241
1.2
518
2.2
12.
42.
42.
42.
42.
42.
41.
91.
91.
91.
91.
91.
91
3.0
3.0
3.0
3.0
3.0
3.0
3/4
782.
360
92.
64
5.1
5.1
5.1
5.1
5.1
5.1
6.6
6.6
6.6
6.6
6.6
6.6
38.
58.
58.
58.
58.
58.
55/
659
1.8
496
2.1
23.
40.
00.
01.
93.
73.
74.
00.
00.
02.
34.
64.
62
5.0
0.0
0.0
2.8
5.5
5.5
7/m
ax81
2.4
780
3.3
11.
20.
00.
01.
73.
43.
41.
30.
00.
01.
63.
13.
11
1.4
0.0
0.0
1.6
3.2
3.2
apa
ts=
patie
nts
patd
ays=
patie
ntda
ysN
B=
Nos
ocom
ialB
acte
rem
ia;C
AB
=C
athe
ter
Ass
ocia
ted
NB
b#=
crud
enu
mbe
r;pa
ts/p
atda
ys%
=pe
rcen
tage
ofto
talp
ats/
patd
ays;
NB
%=
#N
B/1
00pa
tient
s;N
Bin
cd=
#N
B/1
000
patie
ntda
ys;C
AB
incd
=#
NP
/100
0C
athe
ter
days
(bef
ore
1stN
B);
Scientific Institute Public Health, Brussels, 12 Nov 2015 12:26:12 32
Surveillance of ICU-acquired InfectionsNational Feedback Report Risk Factor Indicators Year 2013
Tabl
e33
:P
neum
onia
and
Ant
ibio
ticU
se
pats
apa
tday
saN
Pa
IAP
a
#b%
b#b
%b
#b%
bin
cdb
#bin
cdb
agg
agg
agg
agg
agg
agg
p10
p25
p50
p75
p90
agg
p10
p25
p50
p75
p90
agg
agg
p10
p25
p50
p75
p90
tota
lAn
tib
ioti
cU
sed
ays
012
03.
693
23.
94
3.3
2.0
2.0
3.9
5.3
5.3
4.3
3.1
3.1
4.3
7.0
7.0
314
.213
.213
.214
.115
.615
.61
220.
714
50.
62
9.1
0.0
0.0
8.3
12.5
12.5
13.8
0.0
0.0
10.9
21.7
21.7
250
.029
.429
.498
.016
6.7
166.
72/
311
93.
664
42.
79
7.6
6.7
6.7
7.7
11.8
11.8
14.0
9.9
9.9
14.0
17.4
17.4
529
.914
.914
.943
.520
0.0
200.
04/
614
54.
493
73.
95
3.4
1.9
1.9
3.9
6.3
6.3
5.3
3.2
3.2
5.9
8.8
8.8
313
.58.
38.
314
.529
.429
.4>
=7
207
6.2
2644
11.1
104.
80.
00.
02.
625
.825
.83.
80.
00.
02.
012
.612
.66
5.2
0.0
0.0
4.8
11.0
11.0
SD
DA
nti
bio
tic
Use
day
s0
613
18.4
5302
22.3
304.
92.
82.
83.
310
.210
.25.
73.
33.
33.
812
.112
.119
10.6
6.7
6.7
11.7
13.4
13.4
10
0.0
00.
00
02/
30
0.0
00.
00
04/
60
0.0
00.
00
0>
=7
00.
00
0.0
00
Pro
fyla
ctic
An
tib
oti
cU
sed
ays
048
114
.544
0018
.519
4.0
2.2
2.2
3.1
12.9
12.9
4.3
2.6
2.6
3.4
10.6
10.6
149.
15.
55.
510
.212
.212
.21
170.
589
0.4
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00
0.0
0.0
0.0
0.0
0.0
0.0
2/3
102
3.1
700
2.9
109.
87.
97.
922
.225
.025
.014
.313
.213
.213
.824
.424
.44
19.5
11.8
11.8
33.3
200.
020
0.0
4/6
100.
387
0.4
110
.00.
00.
00.
025
.025
.011
.50.
00.
00.
018
.218
.21
38.5
0.0
0.0
0.0
58.8
58.8
>=
73
0.1
260.
10
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
00.
00.
00.
00.
00.
00.
0
Em
pir
ical
An
tib
ioti
cU
sed
ays
026
27.
917
927.
513
5.0
2.5
2.5
4.3
7.1
7.1
7.3
3.0
3.0
6.3
12.2
12.2
817
.57.
97.
918
.326
.526
.51
220.
713
90.
62
9.1
0.0
0.0
7.1
20.0
20.0
14.4
0.0
0.0
13.5
17.9
17.9
251
.30.
00.
034
.516
6.7
166.
72/
372
2.2
617
2.6
45.
60.
00.
05.
36.
56.
56.
50.
00.
06.
87.
27.
23
18.1
0.0
0.0
17.1
27.8
27.8
4/6
139
4.2
989
4.2
53.
61.
51.
53.
415
.415
.45.
12.
12.
14.
821
.121
.13
9.7
0.0
0.0
15.4
27.8
27.8
>=
711
83.
517
657.
46
5.1
0.0
0.0
0.0
28.6
28.6
3.4
0.0
0.0
0.0
11.4
11.4
33.
70.
00.
00.
09.
39.
3
apa
ts=
patie
nts
patd
ays=
patie
ntda
ysN
P=
Nos
ocom
ialP
neum
onia
;IA
P=
Intu
batio
nA
ssoc
iate
dN
Pb
#=cr
ude
num
ber;
pats
/pat
days
%=
perc
enta
geof
tota
lpat
s/pa
tday
s;N
P%
=#
NP
/100
patie
nts;
NP
incd
=#
NP
/100
0pa
tient
days
;IA
Pin
cd=
#N
P/1
000
intu
batio
nda
ys(b
efor
e1s
tNP
);IU
R=
Intu
batio
nU
tiliz
atio
nR
ate,
intu
batio
nda
ys/1
000
patie
ntda
ys
Scientific Institute Public Health, Brussels, 12 Nov 2015 12:26:12 33
Surveillance of ICU-acquired InfectionsNational Feedback Report Risk Factor Indicators Year 2013
Tabl
e34
:B
lood
stre
amIn
fect
ion
and
Ant
ibio
ticU
se
pats
apa
tday
saN
Ba
CA
Ba
#b%
b#b
%b
#b%
bin
cdb
#bin
cdb
agg
agg
agg
agg
agg
agg
p10
p25
p50
p75
p90
agg
p10
p25
p50
p75
p90
agg
agg
p10
p25
p50
p75
p90
tota
lAn
tib
ioti
cU
sed
ays
013
34.
011
644.
91
0.8
0.0
0.0
0.0
2.0
2.0
0.9
0.0
0.0
0.0
2.5
2.5
11.
40.
00.
00.
04.
34.
31
200.
610
00.
40
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
00.
00.
00.
00.
00.
00.
02/
311
13.
353
92.
31
0.9
0.0
0.0
0.0
7.7
7.7
1.9
0.0
0.0
0.0
9.9
9.9
12.
20.
00.
00.
013
.913
.94/
614
44.
386
93.
74
2.8
0.0
0.0
3.9
6.3
6.3
4.6
0.0
0.0
6.2
10.0
10.0
48.
60.
00.
09.
912
.312
.3>
=7
205
6.2
2630
11.1
83.
91.
31.
33.
014
.814
.83.
01.
01.
02.
77.
87.
87
3.5
1.6
1.6
2.3
8.4
8.4
SD
DA
nti
bio
tic
Use
day
s0
613
18.4
5302
22.3
142.
30.
50.
53.
23.
33.
32.
60.
50.
53.
73.
83.
813
3.5
1.0
1.0
4.2
4.6
4.6
10
0.0
00.
00
02/
30
0.0
00.
00
04/
60
0.0
00.
00
0>
=7
00.
00
0.0
00
Pro
fyla
ctic
An
tib
oti
cU
sed
ays
048
914
.746
2319
.411
2.2
0.5
0.5
2.7
5.8
5.8
2.4
0.6
0.6
3.0
4.5
4.5
103.
21.
11.
13.
65.
15.
11
170.
589
0.4
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00
0.0
0.0
0.0
0.0
0.0
0.0
2/3
942.
849
92.
12
2.1
0.0
0.0
1.2
12.5
12.5
4.0
0.0
0.0
2.5
14.1
14.1
24.
40.
00.
02.
615
.615
.64/
610
0.3
650.
31
10.0
0.0
0.0
0.0
16.7
16.7
15.4
0.0
0.0
0.0
25.6
25.6
119
.20.
00.
00.
038
.538
.5>
=7
30.
126
0.1
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00
0.0
0.0
0.0
0.0
0.0
0.0
Em
pir
ical
An
tib
ioti
cU
sed
ays
027
08.
120
198.
55
1.9
0.0
0.0
0.9
4.9
4.9
2.5
0.0
0.0
1.3
5.6
5.6
53.
60.
00.
01.
48.
88.
81
200.
694
0.4
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00.
00
0.0
0.0
0.0
0.0
0.0
0.0
2/3
702.
151
82.
22
2.9
0.0
0.0
2.3
12.5
12.5
3.9
0.0
0.0
3.0
16.9
16.9
12.
70.
00.
00.
018
.518
.54/
613
64.
194
04.
02
1.5
0.0
0.0
1.5
1.8
1.8
2.1
0.0
0.0
2.1
2.5
2.5
23.
70.
00.
03.
15.
85.
8>
=7
117
3.5
1731
7.3
54.
30.
00.
05.
016
.716
.72.
90.
00.
03.
67.
07.
05
3.9
0.0
0.0
4.4
7.7
7.7
apa
ts=
patie
nts
patd
ays=
patie
ntda
ysN
B=
Nos
ocom
ialB
acte
rem
ia;C
AB
=C
athe
ter
Ass
ocia
ted
NB
b#=
crud
enu
mbe
r;pa
ts/p
atda
ys%
=pe
rcen
tage
ofto
talp
ats/
patd
ays;
NB
%=
#N
B/1
00pa
tient
s;N
Bin
cd=
#N
B/1
000
patie
ntda
ys;C
AB
incd
=#
NP
/100
0C
athe
ter
days
(bef
ore
1stN
B);
Scientific Institute Public Health, Brussels, 12 Nov 2015 12:26:12 34
Surveillance of ICU-acquired InfectionsNational Feedback Report Risk Factor Indicators Year 2013
Table 35: Standardized Pneumonia and Bacteremia Rates
Expecteda Observed/Expecteda
agg agg p10 p25 p50 p75 p90
Nosocomial Bacteremia 19.00 1.00 0.00 0.22 0.95 1.37 1.41Nosocomial Pneumonia 28.00 1.00 0.00 0.52 0.89 3.53 4.86
a Expected=number of infection as predicted by risk factors for Pneumonia andBacteremia Observed/Expected=number of observed infections divided by expectednumber of infections
Scientific Institute Public Health, Brussels, 12 Nov 2015 12:26:12 35
Surveillance of ICU-acquired InfectionsNational Feedback Report Risk Factor Indicators Year 2013
Tabl
e36
:N
osoc
omia
lPne
umon
iaan
dB
acte
rem
iaris
ksc
ore
dist
ribut
ion
pats
apa
tday
saN
P,N
Ba
IAP,
CA
Ba
#b%
b#b
%b
#b%
bin
cdb
#bin
cdb
agg
agg
agg
agg
agg
agg
p10
p25
p50
p75
p90
agg
p10
p25
p50
p75
p90
agg
agg
p10
p25
p50
p75
p90
No
soco
mia
lPn
eum
on
iaR
isk
Sco
re≤
915
64.
711
204.
70
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
00.
00.
00.
00.
00.
00.
010
/19
190
5.7
1411
5.9
31.
60.
00.
00.
01.
311
.12.
10.
00.
00.
01.
518
.20
0.0
0.0
0.0
0.0
0.0
0.0
20/2
913
03.
985
63.
63
2.3
0.0
0.0
4.0
4.5
100.
03.
50.
00.
04.
77.
866
.73
12.0
0.0
0.0
11.6
19.2
142.
930
/39
591.
863
72.
72
3.4
0.0
0.0
1.5
9.8
16.7
3.1
0.0
0.0
1.5
6.0
8.9
26.
80.
00.
03.
815
.523
.340
/49
571.
768
82.
99
15.8
0.0
0.0
12.1
25.0
40.0
13.1
0.0
0.0
10.2
18.5
35.7
817
.40.
00.
014
.125
.025
.050
/59
290.
930
11.
36
20.7
14.3
14.3
16.7
50.0
100.
019
.911
.113
.023
.329
.471
.44
18.2
0.0
14.3
16.1
58.8
76.9
≥60
140.
440
71.
75
35.7
16.7
20.8
45.8
83.3
100.
012
.38.
48.
812
.317
.820
.04
13.6
11.5
11.7
12.0
18.2
24.4
No
soco
mia
lBac
tere
mia
Ris
kS
core
≤9
271
8.1
1678
7.1
31.
10.
00.
01.
82.
22.
71.
80.
00.
03.
13.
36.
03
6.3
0.0
0.0
4.5
15.9
19.2
10/1
922
76.
814
396.
14
1.8
0.0
0.0
0.0
2.2
4.9
2.8
0.0
0.0
0.0
3.7
5.7
43.
40.
00.
00.
03.
88.
620
/29
130
3.9
1218
5.1
21.
50.
00.
00.
01.
65.
01.
60.
00.
00.
01.
94.
52
1.9
0.0
0.0
0.0
2.2
5.1
30/3
968
2.0
834
3.5
11.
50.
00.
00.
00.
07.
11.
20.
00.
00.
00.
05.
41
1.3
0.0
0.0
0.0
0.0
6.8
40/4
979
2.4
1259
5.3
78.
90.
00.
010
.215
.425
.05.
60.
00.
05.
511
.117
.56
5.3
0.0
0.0
5.9
8.3
18.9
≥50
100.
320
70.
92
20.0
0.0
0.0
0.0
0.0
66.7
9.7
0.0
0.0
0.0
0.0
14.3
211
.00.
00.
00.
00.
014
.80
0.0
00.
00
..
0.
apa
ts=
patie
nts
patd
ays=
patie
ntda
ysN
P=
Nos
ocom
ialP
neum
onia
;NB
=N
osoc
omia
lBac
tere
mia
;IA
P=
Intu
batio
nA
ssoc
iate
dN
P;C
AB
=C
athe
ter
Ass
ocia
ted
NB
b#=
crud
enu
mbe
r;pa
ts/p
atda
ys%
=pe
rcen
tage
ofto
talp
ats/
patd
ays;
NP
%=
#N
P/1
00pa
tient
s;N
Pin
cd=
#N
P/1
000
patie
ntda
ys;I
AP
incd
=#
NP
/100
0in
tuba
tion
days
(bef
ore
1stN
P);
NB
%=
#N
B/1
00pa
tient
s;N
Bin
cd=
#N
B/1
000
patie
ntda
ys;C
AB
incd
=#
NB
/100
0ca
thet
erda
ys(b
efor
e1s
tNB
);
Scientific Institute Public Health, Brussels, 12 Nov 2015 12:26:12 36
Surveillance of ICU-acquired InfectionsNational Feedback Report Risk Factor Indicators Year 2013
Figure 1: Evolution: SAPS II Score Median
Figure 2: Evolution: Death / DNR (%)
Scientific Institute Public Health, Brussels, 12 Nov 2015 12:26:12 37
Surveillance of ICU-acquired InfectionsNational Feedback Report Risk Factor Indicators Year 2013
Figure 3: Evolution: Intubation days / 1000 patientdays
Figure 4: Evolution: CVC days / 1000 patientdays
Scientific Institute Public Health, Brussels, 12 Nov 2015 12:26:12 38
Surveillance of ICU-acquired InfectionsNational Feedback Report Risk Factor Indicators Year 2013
Figure 5: Evolution: Any AB utilization days / 1000 patientdays
Figure 6: Benchhmark: Standardized Pneumonia Ratio
Scientific Institute Public Health, Brussels, 12 Nov 2015 12:26:12 39
Surveillance of ICU-acquired InfectionsNational Feedback Report Risk Factor Indicators Year 2013
Figure 7: Benchhmark: Ventilator Associated Pneumonia versus Standardized Pneumonia Ratio
Scientific Institute Public Health, Brussels, 12 Nov 2015 12:26:12 40
Surveillance of ICU-acquired InfectionsNational Feedback Report Risk Factor Indicators Year 2013
Figure 8: Benchhmark: Standardized Bacteremia Ratio
Scientific Institute Public Health, Brussels, 12 Nov 2015 12:26:12 41
Surveillance of ICU-acquired InfectionsNational Feedback Report Risk Factor Indicators Year 2013
Figure 9: Benchhmark: Catheter Associated Bacteremia versus Standardized Bacteremia Ratio
Scientific Institute Public Health, Brussels, 12 Nov 2015 12:26:12 42